{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:51:35Z","timestamp":1780494695092,"version":"3.54.1"},"reference-count":708,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011975","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T09:48:06Z","timestamp":1448876886000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["First trimester serum tests for Down's syndrome screening"],"prefix":"10.1002","volume":"2015","author":[{"given":"S Kate","family":"Alldred","sequence":"first","affiliation":[{"name":"The University of Liverpool; Department of Women's and Children's Health; First Floor, Liverpool Women's NHS Foundation Trust Crown Street Liverpool UK L8 7SS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yemisi","family":"Takwoingi","sequence":"additional","affiliation":[{"name":"University of Birmingham; Public Health, Epidemiology and Biostatistics; Edgbaston Birmingham UK B15 2TT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boliang","family":"Guo","sequence":"additional","affiliation":[{"name":"University of Nottingham; School of Medicine; CLAHRC, C floor, IHM, Jubilee Campus University of Nottingham, Triumph Road Nottingham East Midlands UK NG7 2TU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Pennant","sequence":"additional","affiliation":[{"name":"Cambridgeshire County Council; Public Health Directorate; Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J","family":"Deeks","sequence":"additional","affiliation":[{"name":"University of Birmingham; Public Health, Epidemiology and Biostatistics; Edgbaston Birmingham UK B15 2TT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P","family":"Neilson","sequence":"additional","affiliation":[{"name":"The University of Liverpool; Department of Women's and Children's Health; First Floor, Liverpool Women's NHS Foundation Trust Crown Street Liverpool UK L8 7SS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarko","family":"Alfirevic","sequence":"additional","affiliation":[{"name":"The University of Liverpool; Department of Women's and Children's Health; First Floor, Liverpool Women's NHS Foundation Trust Crown Street Liverpool UK L8 7SS"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,30]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1373\/clinchem.2009.139816","article-title":"First- and second-trimester ADAM12s in Down syndrome screening","volume":"56","author":"Baviera","year":"2010","journal-title":"Clinical Chemistry"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000020900","article-title":"Efficiency of ultrasound and biochemical markers for Down's syndrome risk screening. A prospective study","volume":"14","author":"Benattar","year":"1999","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1471-0528.1995.tb11407.x","article-title":"Maternal serum screening for Down's syndrome in the first trimester of pregnancy","volume":"102","author":"Biagiotti","year":"1995","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1471-0528.1998.tb10239.x","article-title":"First trimester screening for Down's syndrome using maternal serum PAPP-A and free beta-hCG in combination with fetal nuchal translucency thickness","volume":"105","author":"Biagiotti","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1471-0528.1993.tb12973.x","article-title":"Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype","volume":"100","author":"Brambati","year":"1993","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/pd.1970141106","article-title":"Serum PAPP-A and free beta-hCG are first-trimester screening markers for Down syndrome","volume":"14","author":"Brambati","year":"1994","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1479-828X.2008.00912.x","article-title":"First trimester predictors of adverse pregnancy outcomes","volume":"48","author":"Brameld","year":"2008","journal-title":"Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0008|cit8","first-page":"918","article-title":"Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy","volume":"84","author":"Brizot","year":"1994","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/(SICI)1097-0223(199605)16:5<405::AID-PD868>3.0.CO;2-Y","article-title":"First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and beta-hCG","volume":"16","author":"Casals","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/(SICI)1097-0223(199910)19:10<905::AID-PD658>3.0.CO;2-Q","article-title":"The proform of eosinophil major basic protein: a new maternal serum marker for Down syndrome","volume":"19","author":"Christiansen","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j..2004.00177.x","article-title":"Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers","volume":"65","author":"Christiansen","year":"2004","journal-title":"Clinical Genetics"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1399-0004.2005.00441.x","article-title":"Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester","volume":"68","author":"Christiansen","year":"2005","journal-title":"Clinical Genetics"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pd.1600","article-title":"Human placental lactogen is a first-trimester maternal serum marker of Down syndrome","volume":"27","author":"Christiansen","year":"2007","journal-title":"Prenatal Diagnosis"},{"issue":"13","key":"10.1002\/14651858.CD011975-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/pd.2398","article-title":"Placental growth hormone and growth hormone binding protein are first trimester maternal serum markers of Down syndrome","volume":"29","author":"Christiansen","year":"2009","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/pd.2405","article-title":"ADAM 12 may be used to reduce the false positive rate of first trimester combined screening for Down syndrome","volume":"30","author":"Christiansen","year":"2010","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/pd.2496","article-title":"First trimester maternal serum placental growth factor in trisomy 21 pregnancies","volume":"30","author":"Cowans","year":"2010","journal-title":"Prenatal Diagnosis"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD011975-BIB0017|cit17","first-page":"1864-7; discuss","article-title":"Maternal serum screening for alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 11 and 15 weeks of pregnancy to detect fetal chromosome abnormalities.[see comment]","volume":"168","author":"Crandall","year":"1993","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1471-0528.2002.01394.x","article-title":"Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study","volume":"109","author":"Crossley","year":"2002","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/(SICI)1097-0223(199905)19:5<458::AID-PD569>3.0.CO;2-A","article-title":"Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency","volume":"19","author":"Graaf","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0009-9120(95)00021-Z","article-title":"Screening for Down syndrome during the first and second trimesters: impact of risk estimation parameters","volume":"28","author":"Forest","year":"1995","journal-title":"Clinical Biochemistry"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0009-9120(97)00004-0","article-title":"Screening for Down syndrome during first trimester: a prospective study using free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A","volume":"30","author":"Forest","year":"1997","journal-title":"Clinical Biochemistry"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/pd.1217","article-title":"Population screening for fetal trisomy 21: easy access to screening should be balanced against a uniform ultrasound protocol","volume":"25","author":"Gyselaers","year":"2005","journal-title":"Prenatal Diagnosis"},{"issue":"14","key":"10.1002\/14651858.CD011975-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM199804023381404","article-title":"Screening of maternal serum for fetal Down's syndrome in the first trimester","volume":"338","author":"Haddow","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/uog.6318","article-title":"Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation","volume":"33","author":"Kagan","year":"2009","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/uog.6412","article-title":"Prospective validation of first-trimester combined screening for trisomy 21","volume":"34","author":"Kagan","year":"2009","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/uog.7663","article-title":"Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing","volume":"36","author":"Kagan","year":"2010","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.6264","article-title":"Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation","volume":"33","author":"Kagan","year":"2009","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/uog.5331","article-title":"Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A","volume":"31","author":"Kagan","year":"2008","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/uog.5332","article-title":"First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics","volume":"31","author":"Kagan","year":"2008","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/humrep\/den224","article-title":"Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A","volume":"23","author":"Kagan","year":"2008","journal-title":"Human Reproduction"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/(SICI)1097-0223(199810)18:10<1086::AID-PD393>3.0.CO;2-8","article-title":"Schwangerschafts protein 1 (SP1) adds little to the Age-related detection of fetal Down syndrome in the first trimester of pregnancy","volume":"18","author":"Kornman","year":"1998","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-2006-926714","article-title":"Comparing first trimester screening performance: routine care gynaecologists' practices vs. prenatal centre","volume":"28","author":"Kozlowski","year":"2007","journal-title":"Ultraschall in der Medizin"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-2006-926714","article-title":"Comparing first trimester screening performance: routine care gynaecologists' practices vs. prenatal centre","volume":"28","author":"Kozlowski","year":"2007","journal-title":"Ultraschall in der Medizin"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0034|cit34","first-page":"207","article-title":"First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency","volume":"96","author":"Krantz","year":"2000","journal-title":"Obstetrics and Gynecology"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/pd.1970111003","article-title":"First-trimester uneuploidy screening using serum human chorionic gonadotropin (hCG), free alphahCG, and progesterone","volume":"11","author":"Kratzer","year":"1991","journal-title":"Prenatal Diagnosis"},{"issue":"13","key":"10.1002\/14651858.CD011975-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/pd.762","article-title":"ADAM12: a novel first-trimester maternal serum marker for Down syndrome","volume":"23","author":"Laigaard","year":"2003","journal-title":"Prenatal Diagnosis"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/pd.1970130705","article-title":"First-trimester maternal serum Schwangerschafts protein 1 (SP1) in pregnancies associated with chromosomal anomalies","volume":"13","author":"Macintosh","year":"1993","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/pd.700","article-title":"First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers","volume":"23","author":"Muller","year":"2003","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/0002-9378(88)90449-8","article-title":"First-trimester maternal serum alpha-fetoprotein screening for chromosome defects","volume":"159","author":"Milunsky","year":"1988","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/pd.1970100905","article-title":"First-trimester maternal serum alpha-fetoprotein and human chorionic gonadotropin screening for chromosome defects","volume":"10","author":"Nebiolo","year":"1990","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.ejhg.5200655","article-title":"Evaluation of first trimester maternal serum and ultrasound screening for Down's syndrome in Eastern and Northern Finland","volume":"9","author":"Niemimaa","year":"2001","journal-title":"European Journal of Human Genetics"},{"key":"10.1002\/14651858.CD011975-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1471-0528.1995.tb09065.x","article-title":"Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy","volume":"102","author":"Brizot","year":"1995","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1469-0705.1995.06060390.x","article-title":"Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free beta-hCG and fetal nuchal translucency thickness","volume":"6","author":"Noble","year":"1995","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1471-0528.1997.tb11470.x","article-title":"Maternal serum 1T Inhibin-A and free beta-hCG concentrations in trisomy 21 pregnancies at 10 to 14 weeks of gestation","volume":"104","author":"Noble","year":"1997","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/01.AOG.0000207562.09858.16","article-title":"First-trimester combined screening for Down syndrome and other fetal anomalies","volume":"107","author":"O'Leary","year":"2006","journal-title":"Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1469-0705.1997.10060381.x","article-title":"First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency","volume":"10","author":"Orlandi","year":"1997","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/pd.1778","article-title":"Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy","volume":"27","author":"Palomaki","year":"2007","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/(SICI)1097-0223(199702)17:2<101::AID-PD4>3.0.CO;2-H","article-title":"Schwangerschaftsprotein 1 (SP1) as a maternal serum marker for Down syndrome in the first and second trimesters","volume":"17","author":"Qin","year":"1997","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/uog.7549","article-title":"Comparison of first-trimester contingent screening strategies for Down syndrome","volume":"35","author":"Sahota","year":"2010","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/uog.7677","article-title":"Comparison of likelihood ratios of first-trimester nuchal translucency measurements: multiples of median, delta or mixture","volume":"36","author":"Sahota","year":"2010","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejogrb.2009.03.007","article-title":"Examination of a first-trimester Down syndrome screening concept on a mix of 11,107 high- and low-risk patients at a private center for prenatal medicine in Germany","volume":"144","author":"Schaelike","year":"2009","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1479-828X.2004.00205.x","article-title":"Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population","volume":"44","author":"Scott","year":"2004","journal-title":"Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1469-0705.1999.13040231.x","article-title":"A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.[see comment]","volume":"13","author":"Spencer","year":"1999","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/pd.351","article-title":"Maternal serum hyperglycosylated human chorionic gonadotrophin (HhCG) in the first trimester of pregnancies affected by Down syndrome, using a sialic acid-specific lectin immunoassay.[see comment]","volume":"22","author":"Spencer","year":"2002","journal-title":"Prenatal Diagnosis"},{"key":"10.1002\/14651858.CD011975-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1477-7827-8-129","article-title":"First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker","volume":"8","author":"Torring","year":"2010","journal-title":"Reproductive Biology & Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/(SICI)1097-0223(199906)19:6<499::AID-PD555>3.0.CO;2-6","article-title":"Maternal serum screening for Down syndrome in the first trimester: experience from Belarus","volume":"19","author":"Tsukerman","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ajog.2006.11.040","article-title":"Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in northern Finland","volume":"196","author":"Valinen","year":"2007","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/14767050902755478","article-title":"Effect of a new marker, ADAM12, on Down risk figures in first trimester screening","volume":"22","author":"Valinen","year":"2009","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/pd.1970120604","article-title":"First-trimester maternal serum human chorionic gonadotrophin as a marker for fetal chromosomal disorders","volume":"12","author":"Lith","year":"1992","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.semperi.2005.05.006","article-title":"SURUSS in perspective","volume":"29","author":"Wald","year":"2005","journal-title":"Seminars in Perinatology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1471-0528.2004.00193.x","article-title":"SURUSS in perspective.[see comment]","volume":"111","author":"Wald","year":"2004","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0063|cit62","first-page":"56","article-title":"First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)","volume":"10","author":"Wald","year":"2003","journal-title":"Journal of Medical Screening"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0062|cit63","first-page":"1","article-title":"First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)","volume":"7","author":"Wald","year":"2003","journal-title":"Health Technology Assessment (Winchester, England)"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/pd.1970150410","article-title":"Evaluation of maternal serum dimeric 1T Inhibin A as a first-trimester marker of Down's syndrome","volume":"15","author":"Wallace","year":"1995","journal-title":"Prenatal Diagnosis"},{"issue":"15","key":"10.1002\/14651858.CD011975-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJMoa025273","article-title":"First-trimester screening for trisomies 21 and 18.[see comment]","volume":"349","author":"Wapner","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/j.semperi.2005.05.013","article-title":"First trimester screening: the BUN study","volume":"29","author":"Wapner","year":"2005","journal-title":"Seminars in Perinatology"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1373\/clinchem.2005.048751","article-title":"Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) as a first-trimester serum marker for Down syndrome","volume":"51","author":"Weinans","year":"2005","journal-title":"Clinical Chemistry"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/uog.1834","article-title":"Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women","volume":"25","author":"Wojdemann","year":"2005","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/uog.6331","article-title":"Maternal serum placental growth factor at 11-13 weeks in chromosomally abnormal pregnancies","volume":"33","author":"Zaragoza","year":"2009","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1471-0528.1995.tb11362.x","article-title":"Fetal and maternal hCG concentration in aneuploid pregnancies","volume":"102","author":"Abbas","year":"1995","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/01443610410001685475","article-title":"Maternal serum screening for trisomy 21 in women with a false positive result in last pregnancy","volume":"24","author":"Abdul-Hamid","year":"2004","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/(SICI)1097-0223(199904)19:4<334::AID-PD541>3.0.CO;2-E","article-title":"Maternal serum S100 protein in normal and Down syndrome pregnancies","volume":"19","author":"Abraha","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.7863\/jum.2010.29.10.1445","article-title":"Role of first-trimester sonography in the diagnosis of aneuploidy and structural fetal anomalies","volume":"29","author":"Abu-Rustum","year":"2010","journal-title":"Journal of Ultrasound in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/uog.7542","article-title":"Umbilical vein anomaly in fetuses with Down syndrome","volume":"35","author":"Achiron","year":"2010","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"857","key":"10.1002\/14651858.CD011975-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1259\/bjr.72.857.10505009","article-title":"Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population","volume":"72","author":"Adekunle","year":"1999","journal-title":"British Journal of Radiology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pd.2399","article-title":"Influence of maternal BMI on genetic sonography in the FaSTER trial","volume":"30","author":"Agaard-Tillery","year":"2010","journal-title":"Prenatal Diagnosis"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/pd.1970130804","article-title":"First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects","volume":"13","author":"Aitken","year":"1993","journal-title":"Prenatal Diagnosis"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/(SICI)1097-0223(199611)16:11<1051::AID-PD988>3.0.CO;2-T","article-title":"Heat-stable and immunoreactive placental alkaline phosphatase in maternal serum from Down's syndrome and trisomy 18 pregnancies.[see comment]","volume":"16","author":"Aitken","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"19","key":"10.1002\/14651858.CD011975-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJM199605093341904","article-title":"Dimeric Inhibin A as a marker for Down's syndrome in early pregnancy","volume":"334","author":"Aitken","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0080|cit80","first-page":"162","article-title":"Is there any effect of fetal gender on the markers of first trimester Down's syndrome screening?","volume":"38","author":"Ajayi","year":"2011","journal-title":"Clinical and Experimental Obstetrics & Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1515\/CCLM.2001.080","article-title":"Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18","volume":"39","author":"Akbas","year":"2001","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/14767050902994572","article-title":"Predictive value of increased nuchal translucency as a screening test for the detection of fetal chromosomal abnormalities","volume":"22","author":"Alexioy","year":"2009","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/GIM.0b013e3182036763","article-title":"Prospective validation of quantitative fluorescent polymerase chain reaction for rapid detection of common aneuploidies","volume":"13","author":"Allingham-Hawkins","year":"2011","journal-title":"Genetics in Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0084|cit84","first-page":"527","article-title":"[Share with women. Prenatal tests for Down syndrome]. [Spanish]","volume":"54","author":"American","year":"2009","journal-title":"Journal of Midwifery & Women's Health"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/(SICI)1097-0223(199811)18:11<1122::AID-PD414>3.0.CO;2-P","article-title":"Inhibin A and pro-alphaC Inhibin Ain Down syndrome and normal pregnancies","volume":"18","author":"Antona","year":"1998","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/01443619965002","article-title":"Pregnant women of 35 years of age or more: Maternal serum markers or amniocentesis?","volume":"19","author":"Antsaklis","year":"1999","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0087|cit87","first-page":"1123","article-title":"Specificity of fetal tricuspid regurgitation in prediction of Down syndrome in Thai fetuses at 17-23 weeks of gestation","volume":"92","author":"Anuwutnavin","year":"2009","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ajmg.1320260304","article-title":"Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs","volume":"26","author":"Ashwood","year":"1987","journal-title":"American Journal of Medical Genetics"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0089|cit89","first-page":"174","article-title":"Triple marker","volume":"7","author":"Asrani","year":"2005","journal-title":"National Journal of Homoeopathy"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1469-0705.2001.00457.x","article-title":"Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study","volume":"18","author":"Audibert","year":"2001","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1159\/000092472","article-title":"Umbilical cord diameter at 11-14 weeks of gestation: Relationship to nuchal translucency, ductus venous blood flow and chromosomal defects","volume":"21","author":"Axt","year":"2006","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1067\/mob.2002.123201","article-title":"A novel method for the detection of Down syndrome with the use of four serum markers","volume":"187","author":"Azuma","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1-2","key":"10.1002\/14651858.CD011975-BIB0093|cit93","first-page":"59","article-title":"Maternal serum alpha fetoprotein among pregnant females in Alexandria","volume":"79","author":"Baghagho","year":"2004","journal-title":"Journal of the Egyptian Public Health Association"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/0002-9378(95)91334-3","article-title":"Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple-screen results","volume":"173","author":"Bahado-Singh","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4 I","key":"10.1002\/14651858.CD011975-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0002-9378(96)80006-8","article-title":"Risk of Down syndrome and any clinically significant chromosome defect in pregnancies with abnormal triple-screen and normal targeted ultrasonographic results","volume":"175","author":"Bahado-Singh","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2 I","key":"10.1002\/14651858.CD011975-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0002-9378(99)70237-1","article-title":"Nuchal thickness, urine \u00df-core fragment level, and maternal age for down syndrome screening","volume":"180","author":"Bahado-Singh","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1067\/mob.2002.121651","article-title":"The comprehensive midtrimester test: high-sensitivity Down syndrome test","volume":"186","author":"Bahado-Singh","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/sper.2003.50013","article-title":"Combined serum and ultrasound screening for detection of fetal aneuploidy","volume":"27","author":"Bahado-Singh","year":"2003","journal-title":"Seminars in Perinatology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.AOG.0000263470.89007.e3","article-title":"First- and second-trimester evaluation of risk for Down syndrome","volume":"110","author":"Ball","year":"2007","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1023\/A:1009455912670","article-title":"Triple-test screening in in vitro fertilization pregnancies","volume":"18","author":"Bar-Hava","year":"2001","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/(SICI)1097-0223(199612)16:12<1111::AID-PD998>3.0.CO;2-X","article-title":"Down's syndrome screening marker levels following assisted reproduction","volume":"16","author":"Barkai","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/pd.1970151209","article-title":"Enhanced twin pregnancy detection within an open neural tube defect and Down syndrome screening protocol using free-\u00df hCG and AFP","volume":"15","author":"Barnabei","year":"1995","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF00451454","article-title":"Maternal levels of pregnancy-specific \u00df 1-glycoprotein (SP-1) are elevated in pregnancies affected by Down's syndrome","volume":"80","author":"Bartels","year":"1988","journal-title":"Human Genetics"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/pd.1970130207","article-title":"Adjustment formulae for maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol to maternal weight and smoking","volume":"13","author":"Bartels","year":"1993","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0105|cit105","first-page":"897","article-title":"Ultrasound detection of fetal aneuploidy in women with elevated maternal serum alpha-fetoprotein","volume":"77","author":"Barth","year":"1991","journal-title":"Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0106|cit106","first-page":"877","article-title":"[Abnormal second trimester screening for fetal chromosomal abnormalities as a predictor of adverse pregnancy outcome]. [Polish]","volume":"78","author":"Bas-Budecka","year":"2007","journal-title":"Ginekologia Polska"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/jmf.16.4.241.243-26","article-title":"Placental growth hormone in Down's syndrome screening","volume":"16","author":"Baviera","year":"2004","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/(SICI)1096-8628(19980413)76:5<369::AID-AJMG1>3.0.CO;2-I","article-title":"Fetal gender impact on multiple-marker screening results","volume":"76","author":"Bazzett","year":"1998","journal-title":"American Journal of Medical Genetics"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000116739","article-title":"Risk of chromosome abnormalities in the presence of bilateral or unilateral choroid plexus cysts","volume":"23","author":"Beke","year":"2008","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1093\/humrep\/dei107","article-title":"First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction","volume":"20","author":"Bellver","year":"2005","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0002-9378(95)90272-4","article-title":"Prenatal diagnosis of diverse chromosome abnormalities in a population of women identified by triple-marker testing as screen positive for Down syndrome","volume":"173","author":"Benn","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0112|cit112","first-page":"323","article-title":"Maternal serum screening for birth defects: results of a Connecticut regional program","volume":"60","author":"Benn","year":"1996","journal-title":"Connecticut Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/clinchem\/43.2.333","article-title":"Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups","volume":"43","author":"Benn","year":"1997","journal-title":"Clinical Chemistry"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1097-0223(199804)18:4<319::AID-PD261>3.0.CO;2-Q","article-title":"Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies","volume":"18","author":"Benn","year":"1998","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/1097-0223(200101)21:1<46::AID-PD984>3.0.CO;2-C","article-title":"Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results","volume":"21","author":"Benn","year":"2001","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0116|cit116","first-page":"1168","article-title":"Combined second-trimester biochemical and ultrasound screening for Down syndrome","volume":"100","author":"Benn","year":"2002","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0117|cit117","first-page":"451","article-title":"Incorporation of inhibin-A in second-trimester screening for Down syndrome","volume":"101","author":"Benn","year":"2003","journal-title":"Obstetrics and Gynecology"},{"issue":"9360","key":"10.1002\/14651858.CD011975-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(03)12718-3","article-title":"Improved antenatal screening for Down's syndrome","volume":"361","author":"Benn","year":"2003","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/pd.1215","article-title":"Practical strategies in contingent sequential screening for Down syndrome","volume":"25","author":"Benn","year":"2005","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10897-005-6390-7","article-title":"Sequential Down syndrome screening: the importance of first and second trimester test correlations when calculating risk","volume":"14","author":"Benn","year":"2005","journal-title":"Journal of Genetic Counseling"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ajog.2007.06.054","article-title":"Stepwise sequential screening for fetal aneuploidy","volume":"197","author":"Benn","year":"2007","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/pd.1970150609","article-title":"Analysis of maternal serum alpha-fetoprotein and free \u00df human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening","volume":"15","author":"Berry","year":"1995","journal-title":"Prenatal Diagnosis"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1471-0528.1997.tb12025.x","article-title":"Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters","volume":"104","author":"Berry","year":"1997","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1471-0528.1994.tb13042.x","article-title":"First trimester maternal serum pregnancy-associated plasma protein A and pregnancy-specific \u00df 1-glycoprotein in fetal trisomies","volume":"101","author":"Bersinger","year":"1994","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0923-2532(00)80038-1","article-title":"Glycosylation of pregnancy-associated plasma protein a (PAPP-A) and pregnancy-specific (\u00df)(1)-glycoprotein (SP1): Relevance for fetal down syndrome screening and for placental function studies","volume":"15","author":"Bersinger","year":"2000","journal-title":"Immuno-Analyse et Biologie Specialisee"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0126|cit126","first-page":"7","article-title":"Serum levels of placenta protein markers: The relevance of differences between spontaneous and after in vitro fertilization pregnancies for fetal trisomy screening","volume":"11","author":"Bersinger","year":"2001","journal-title":"Journal fur Fertilitat und Reproduktion"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/pd.547","article-title":"First-trimester maternal serum PAPP-A, SP1 and M-CSF levels in normal and trisomic twin pregnancies","volume":"23","author":"Bersinger","year":"2003","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/pd.910","article-title":"Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screening","volume":"24","author":"Bersinger","year":"2004","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.immbio.2004.11.006","article-title":"First trimester serum concentrations of placental proteins in singleton and multiple IVF pregnancies: Implications for Down syndrome screening","volume":"20","author":"Bersinger","year":"2005","journal-title":"Immuno-Analyse et Biologie Specialisee"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1258\/jms.2008.008049","article-title":"First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency","volume":"15","author":"Bestwick","year":"2008","journal-title":"Journal of Medical Screening"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajog.2003.09.028","article-title":"An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years","volume":"190","author":"Biggio","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/uog.7766","article-title":"Low-resistance hepatic artery flow in first-trimester fetuses: an ominous sign","volume":"37","author":"Bilardo","year":"2011","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00003081-200209000-00010","article-title":"Screening for chromosomal defects by fetal nuchal translucency at 11 to 14 weeks","volume":"45","author":"Bindra","year":"2002","journal-title":"Clinical Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1097-0223(199903)19:3<219::AID-PD512>3.0.CO;2-K","article-title":"Clinical follow-up of high mid-trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnancies","volume":"19","author":"Blundell","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD011975-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/AOG.0b013e3181cbc652","article-title":"Comparison of multiplex ligation-dependent probe amplification and karyotyping in prenatal diagnosis","volume":"115","author":"Boormans","year":"2010","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0136|cit136","first-page":"25","article-title":"Maternal serum alpha-fetoprotein prenatal screening for Down syndrome","volume":"59","author":"Boots","year":"1989","journal-title":"Alabama Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/JPM.2009.032","article-title":"Advanced maternal age as a sole indication for genetic amniocentesis; risk-benefit analysis based on a large database reflecting the current common practice","volume":"37","author":"Bornstein","year":"2009","journal-title":"Journal of Perinatal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajog.2009.01.017","article-title":"Comparison of modes of ascertainment for mosaic vs complete trisomy 21","volume":"200","author":"Bornstein","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ajog.2010.06.019","article-title":"Complete trisomy 21 vs translocation Down syndrome: a comparison of modes of ascertainment","volume":"203","author":"Bornstein","year":"2010","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0140|cit140","first-page":"384","article-title":"[Evaluation of pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of human chorionic gonadotropin (beta hCG) levels and sonographic assesement of fetal nuchal translucency (NT) in singleton pregnancies between 11 and 14 weeks of gestation--Polish multi-centre research]. [Polish]","volume":"78","author":"Borowski","year":"2007","journal-title":"Ginekologia Polska"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/uog.5187","article-title":"Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21","volume":"30","author":"Borrell","year":"2007","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0142|cit142","first-page":"235","article-title":"Role of ultrasound evaluation of nuchal translucency in prenatal diagnosis","volume":"29","author":"Borruto","year":"2002","journal-title":"Clinical and Experimental Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/uog.6220","article-title":"Second-trimester genetic sonogram for detection of fetal chromosomal abnormalities in a community-based antenatal testing unit","volume":"33","author":"Bottalico","year":"2009","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/00008480-199012000-00019","article-title":"Screening for Down's syndrome with maternal serum human chorionic gonadotropin at midtrimester","volume":"2","author":"Boue","year":"1990","journal-title":"Current Opinion in Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0145|cit145","first-page":"168","article-title":"Triple marker screening for fetal Down syndrome","volume":"9","author":"Bradley","year":"1994","journal-title":"International Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0146|cit146","first-page":"75","article-title":"Nuchal translucency and screening for Down's syndrome","volume":"8","author":"Braithwaite","year":"1996","journal-title":"Contemporary Reviews in Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1469-0705.1995.05010009.x","article-title":"First-trimester Down's syndrome screening using nuchal translucency: a prospective study in women undergoing chorionic villus sampling","volume":"5","author":"Brambati","year":"1995","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0148|cit148","first-page":"155","article-title":"Sonography in the first trimester screening of trisomy 21 and other fetal aneuploidies","volume":"2","author":"Brambati","year":"1996","journal-title":"Early Pregnancy"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0378-3782(95)01658-P","article-title":"Maternal serum Schwangerschafts protein-1 (SP1) and fetal chromosomal abnormalities at 10-13 weeks' gestation","volume":"43","author":"Brizot","year":"1995","journal-title":"Early Human Development."},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1471-0528.1995.tb09022.x","article-title":"First trimester maternal serum alpha-fetoprotein in fetal trisomies","volume":"102","author":"Brizot","year":"1995","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD011975-BIB0151|cit151","first-page":"85","article-title":"Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities","volume":"33","author":"Brizzi","year":"1989","journal-title":"Journal of Nuclear Medicine and Allied Sciences"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/pd.1970100406","article-title":"First-trimester maternal serum biochemical indicators in Down syndrome","volume":"10","author":"Brock","year":"1990","journal-title":"Prenatal Diagnosis"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3109\/00016349.2010.489599","article-title":"Gradual implementation of first trimester screening in a population with a prior screening strategy: population based cohort study","volume":"89","author":"Calda","year":"2010","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jms.8.3.163","article-title":"Correlations between first and second trimester markers for Down's syndrome screening","volume":"8","author":"Campogrande","year":"2001","journal-title":"Journal of Medical Screening"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1471-0528.1988.tb06601.x","article-title":"Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome","volume":"95","author":"Canick","year":"1988","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/pd.1970150809","article-title":"Second-trimester levels of maternal urinary gonadotropin peptide in down syndrome pregnancy","volume":"15","author":"Canick","year":"1995","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1515\/CCLM.2002.103","article-title":"Comparison of first trimester, second trimester and integrated Down's syndrome screening results in unaffected pregnancies","volume":"40","author":"Canini","year":"2002","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/(SICI)1097-0223(199807)18:7<683::AID-PD327>3.0.CO;2-G","article-title":"Population screening for aneuploidy using maternal age and ultrasound","volume":"18","author":"Cans","year":"1998","journal-title":"Prenatal Diagnosis"},{"key":"10.1002\/14651858.CD011975-BIB0159|cit159","first-page":"261","article-title":"[Proposed normal values for alpha fetoprotein in maternal serum for the detection of neural tube closure defects and Down syndrome. Preliminary study]. [Spanish]","volume":"59","author":"Carreras de Paz","year":"1991","journal-title":"Ginecologia y Obstetricia de Mexico"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/pd.1617","article-title":"Nuchal translucency screening: how do women actually utilize the results?","volume":"27","author":"Caughey","year":"2007","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ajog.2008.01.022","article-title":"Combining 'nasal bone length assessment as MoM' with other markers for trisomy 21 screening: could it be more effective?","volume":"198","author":"Cebesoy","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0162|cit162","first-page":"199","article-title":"[Prenatal diagnosis of trisomy 21: the Tunisian experience]. [French]","volume":"18","author":"Chelli","year":"2008","journal-title":"Sante"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0163|cit163","first-page":"846","article-title":"Integrated screening for Down's syndrome","volume":"48","author":"Chen","year":"1999","journal-title":"Journal of Family Practice"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/pd.363","article-title":"The effect of ethnic origin on nuchal translucency at 10-14 weeks of gestation","volume":"22","author":"Chen","year":"2002","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/pd.798","article-title":"Ultrasound screening of fetal structural abnormalities at 12 to 14 weeks in Hong Kong","volume":"24","author":"Chen","year":"2004","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1028-4559(09)60103-0","article-title":"Impact of second-trimester maternal serum screening on prenatal diagnosis of Down syndrome and the use of amniocentesis in the Taiwanese population","volume":"44","author":"Chen","year":"2005","journal-title":"Taiwanese Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/uog.5232","article-title":"Comparison of nuchal and detailed morphology ultrasound examinations in early pregnancy for fetal structural abnormality screening: a randomized controlled trial","volume":"31","author":"Chen","year":"2008","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0168|cit168","first-page":"72","article-title":"A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol","volume":"81","author":"Cheng","year":"1993","journal-title":"Obstetrics and Gynecology"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/(SICI)1097-0223(199910)19:10<955::AID-PD670>3.0.CO;2-X","article-title":"Elevated second-trimester maternal serum hCG in women undergoing haemodialysis","volume":"19","author":"Cheng","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0020-7292(03)00206-6","article-title":"Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening","volume":"84","author":"Cheng","year":"2004","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0002-9378(03)00948-7","article-title":"Elevated maternal midtrimester serum free \u00df-human chorionic gonadotropin levels in vegetarian pregnancies that cause increased false-positive Down syndrome screening results","volume":"190","author":"Cheng","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1067\/mob.2002.125240","article-title":"Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes","volume":"187","author":"Chitayat","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD011975-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"c7401","DOI":"10.1136\/bmj.c7401","article-title":"Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study","volume":"342","author":"Chiu","year":"2011","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/pd.2190","article-title":"Validation of QF-PCR in a Korean population","volume":"29","author":"Cho","year":"2009","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2753.2008.01095.x","article-title":"First-trimester Down syndrome screening in women younger than 35 years old and cost-effectiveness analysis in Taiwan population","volume":"15","author":"Chou","year":"2009","journal-title":"Journal of Evaluation in Clinical Practice"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/pd.297","article-title":"The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome","volume":"22","author":"Christiansen","year":"2002","journal-title":"Prenatal Diagnosis"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/pd.1750","article-title":"ADAM 12 as a second-trimester maternal serum marker in screening for Down syndrome","volume":"27","author":"Christiansen","year":"2007","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/pd.1843","article-title":"First-trimester maternal serum progesterone in aneuploid pregnancies","volume":"28","author":"Christiansen","year":"2008","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0179|cit179","first-page":"17","article-title":"The application of three-dimensional ultrasound to nuchal translucency thickness measurement at 10-14 weeks of gestation","volume":"5","author":"Chung","year":"2000","journal-title":"Prenatal and Neonatal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0180|cit180","first-page":"575","article-title":"Blood screening of Down's syndrome (Trisomy 21) and reimbursement of karyotype for women under 38","volume":"91","author":"Anon","year":"1996","journal-title":"Revue Francaise de Gynecologie et d'Obstetrique"},{"key":"10.1002\/14651858.CD011975-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S0378-3782(96)01819-1","article-title":"Detection of \u00df-core fragment in second trimester Down's syndrome pregnancies","volume":"47 Suppl","author":"Cole","year":"1996","journal-title":"Early Human Development"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0182|cit182","first-page":"95","article-title":"Early screening for chromosomal abnormalities: New strategies combining biochemical, sonographic and doppler parameters","volume":"6","author":"Comas","year":"2001","journal-title":"Prenatal and Neonatal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0183|cit183","first-page":"648","article-title":"Measurement of nuchal translucency as a single strategy in trisomy 21 screening: should we use any other marker?","volume":"100","author":"Comas","year":"2002","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/14722240208500465","article-title":"Early sonographic screening for chromosomal abnormalities","volume":"2","author":"Comas","year":"2002","journal-title":"Ultrasound Review of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ajog.2006.06.006","article-title":"Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?","volume":"195","author":"Comstock","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00006254-199806000-00022","article-title":"Triple-marker test as screening for down syndrome: a meta-analysis","volume":"53","author":"Conde Agudelo","year":"1998","journal-title":"Obstetrical and Gynecological Survey"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/uog.8890","article-title":"Early first-trimester maternal serum placental growth factor in trisomy 21 pregnancies","volume":"37","author":"Cowans","year":"2011","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/pd.1970110204","article-title":"Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age","volume":"11","author":"Crossley","year":"1991","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/pd.1970130406","article-title":"Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay.[see comment]","volume":"13","author":"Crossley","year":"1993","journal-title":"Prenatal Diagnosis"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/(SICI)1097-0223(199611)16:11<1039::AID-PD985>3.0.CO;2-#","article-title":"Insulin-dependent diabetes mellitus and prenatal screening results: current experience from a regional screening programme","volume":"16","author":"Crossley","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/pd.313","article-title":"Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening","volume":"22","author":"Crossley","year":"2002","journal-title":"Prenatal Diagnosis"},{"issue":"8383","key":"10.1002\/14651858.CD011975-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(84)92389-4","article-title":"Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome","volume":"i","author":"Cuckle","year":"1984","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1471-0528.1987.tb03115.x","article-title":"Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level","volume":"94","author":"Cuckle","year":"1987","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1471-0528.1987.tb02301.x","article-title":"Maternal serum alpha-fetoprotein and ethnic origin","volume":"94","author":"Cuckle","year":"1987","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1471-0528.1990.tb01794.x","article-title":"The effect of smoking in pregnancy on maternal serum alpha-fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels","volume":"97","author":"Cuckle","year":"1990","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/(SICI)1097-0223(199612)16:12<1095::AID-PD997>3.0.CO;2-9","article-title":"Combining Inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome","volume":"16","author":"Cuckle","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/(SICI)1097-0223(199906)19:6<513::AID-PD579>3.0.CO;2-L","article-title":"Maternal serum activin A and follistatin levels in pregnancies with Down syndrome","volume":"19","author":"Cuckle","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/(SICI)1097-0223(199906)19:6<505::AID-PD572>3.0.CO;2-6","article-title":"Appropriate biochemical parameters in first-trimester screening for Down syndrome.[see comment]","volume":"19","author":"Cuckle","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/pd.1970101004","article-title":"Diagnosis and significance of cystic hygroma in the first trimester","volume":"10","author":"Cullen","year":"1990","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.7863\/jum.2004.23.10.1327","article-title":"Fetal nasal bone length in euploid and aneuploid fetuses between 11 and 20 weeks' gestation: a prospective study","volume":"23","author":"Cusick","year":"2004","journal-title":"Journal of Ultrasound in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/uog.4091","article-title":"Likelihood ratios for fetal trisomy 21 based on nasal bone length in the second trimester: how best to define hypoplasia?","volume":"30","author":"Cusick","year":"2007","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1469-0705.1997.10060375.x","article-title":"Screening for fetal anomalies by ultrasound at 14 and 21 weeks","volume":"10","author":"D'Ottavio","year":"1997","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0923-2532(01)80075-2","article-title":"Antenatal screening for Dawn's syndrome with serum markers: Influence of maternal weight, smoking habits and diabetes","volume":"16","author":"Dancoine","year":"2001","journal-title":"Immuno-Analyse et Biologie Specialisee"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/jp.2008.14","article-title":"Pregnancy outcome in fetuses with increased nuchal translucency","volume":"28","author":"Dane","year":"2008","journal-title":"Journal of Perinatology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/(SICI)1097-0223(199904)19:4<360::AID-PD556>3.0.CO;2-U","article-title":"First-trimester screening for down syndrome using nuchal translucency measurement with free \u00df-hCG and PAPP-A between 10 and 13 weeks of pregnancy - The combined test","volume":"19","author":"De","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0206|cit206","first-page":"22","article-title":"Down's syndrome: First trimester approach","volume":"13","author":"De","year":"2001","journal-title":"Italian Journal of Gynaecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jms.7.3.163","article-title":"Extent of correlation between first and second trimester markers for Down's syndrome screening","volume":"7","author":"Biasio","year":"2000","journal-title":"Journal of Medical Screening"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1097-0223(200003)20:3<186::AID-PD776>3.0.CO;2-A","article-title":"Co-variables in first trimester maternal serum screening","volume":"20","author":"Graaf","year":"1991","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/(SICI)1097-0223(199905)19:5<458::AID-PD569>3.0.CO;2-A","article-title":"Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency","volume":"19","author":"Graaf","year":"1999","journal-title":"Prenatal Diagnosis."},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3181b6f251","article-title":"Measurement of nuchal translucency and the prenatal diagnosis of Down syndrome","volume":"114","author":"Carmen Saucedo","year":"2009","journal-title":"Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"645","DOI":"10.7863\/jum.2001.20.6.645","article-title":"Combined use of genetic sonography and maternal serum triple-marker screening: an effective method for increasing the detection of trisomy 21 in women younger than 35 years.[see comment]","volume":"20","author":"DeVore","year":"2001","journal-title":"Journal of Ultrasound in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0212|cit212","first-page":"181","article-title":"[Advanced maternal age as an indication for invasive prenatal diagnostics?]. [Czech]","volume":"72","author":"Dhaifalah","year":"2007","journal-title":"Ceska Gynekologie"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0213|cit213","first-page":"19","article-title":"[Efficiency of measuring nasal bone as an ultrasound marker of Down syndrome in 11th to 13th+6 week of pregnancy]. [Czech]","volume":"72","author":"Dhaifalah","year":"2007","journal-title":"Ceska Gynekologie"},{"issue":"9560","key":"10.1002\/14651858.CD011975-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(07)60115-9","article-title":"A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study","volume":"369","author":"Dhallan","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0215|cit215","first-page":"161","article-title":"Multiple marker screening","volume":"161","author":"Dickerson","year":"1994","journal-title":"Western Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJM198708063170603","article-title":"Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels","volume":"317","author":"Dimaio","year":"1987","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0002-9378(86)90655-1","article-title":"Maternal serum alpha-fetoprotein and fetal autosomal trisomies","volume":"154","author":"Doran","year":"1986","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/pd.2051","article-title":"Maternal serum screening in cases of mosaic and translocation Down syndrome","volume":"28","author":"Dreux","year":"2008","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000264328","article-title":"Abnormal biochemical serum screening versus 2nd-trimester ultrasound-detected minor anomalies as predictors of aneuploidy in low-risk women","volume":"11","author":"Drugan","year":"1996","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000264273","article-title":"Multiple marker screening in multifetal gestations: failure to predict adverse pregnancy outcomes","volume":"11","author":"Drugan","year":"1996","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/01443610120113300","article-title":"First-trimester pregnancy scanning as a screening tool for high-risk and abnormal pregnancies in a district general hospital setting","volume":"22","author":"Drysdale","year":"2002","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ajog.2008.06.099","article-title":"Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers","volume":"199","author":"Dugoff","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0223|cit223","first-page":"4","article-title":"Is the integrated test better for screening for Down's syndrome than the traditional triple test?","volume":"2","author":"Ebell","year":"1999","journal-title":"Evidence-Based Practice"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1471-0528.1998.tb09351.x","article-title":"First trimester sonographic detection of chromosomal abnormalities in an unselected population","volume":"105","author":"Economides","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"415","DOI":"10.5858\/2004-128-415-EOADIA","article-title":"Evaluation of a dimeric inhibin-A assay for assessing fetal Down syndrome: establishment, comparison, and monitoring of median concentrations for normal pregnancies","volume":"128","author":"Erickson","year":"2004","journal-title":"Archives of Pathology & Laboratory Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0226|cit226","first-page":"20","article-title":"Similarity of insulin-dependent diabetics' and non-insulin-dependent diabetics' levels of \u00df-hCG and unconjugated estriol with controls: no need to adjust as with alpha-fetoprotein","volume":"3","author":"Evans","year":"1996","journal-title":"Journal of the Society for Gynecologic Investigation"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/01.AOG.0000257614.71418.4c","article-title":"Comparison of serum markers in first-trimester down syndrome screening","volume":"109","author":"Evans","year":"2007","journal-title":"Obstetrics and Gynecology"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/uog.1991","article-title":"Fetal head-to-trunk volume ratio in chromosomally abnormal fetuses at 11 + 0 to 13 + 6 weeks of gestation","volume":"26","author":"Falcon","year":"2005","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/uog.2736","article-title":"Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6-week scan: association with chromosomal defects and reproducibility of the method","volume":"27","author":"Falcon","year":"2006","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1471-0528.1998.tb10229.x","article-title":"The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population.[see comment]","volume":"105","author":"Ford","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0029-7844(97)00139-7","article-title":"Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies","volume":"90","author":"Frishman","year":"1997","journal-title":"Obstetrics and Gynecology"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1034\/j.1600-0412.2000.0790121124.x","article-title":"Detection of aneuploidy with fetal nuchal translucency and maternal serum markers in Japanese women","volume":"79","author":"Fukada","year":"2000","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000224429","article-title":"Is rapid aneuploidy screening used alone acceptable in prenatal diagnosis? An evaluation of the possible role of ultrasound examination","volume":"25","author":"Gaudry","year":"2009","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/pd.2157","article-title":"Should the first-trimester aneuploidy screen be maternal age adjusted? Screening by absolute risk versus risk adjusted to maternal age","volume":"29","author":"Gebb","year":"2009","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijgo.2008.05.028","article-title":"Prenatal diagnosis of chromosomal abnormalities in a resource-poor setting","volume":"103","author":"Geerts","year":"2008","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/uog.7597","article-title":"Nuchal fold thickness, nasal bone absence or hypoplasia, ductus venosus reversed flow and tricuspid valve regurgitation in screening for trisomies 21, 18 and 13 in the early second trimester","volume":"35","author":"Geipel","year":"2010","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD011975-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"b138","DOI":"10.1136\/bmj.b138","article-title":"Comparison of different strategies in prenatal screening for Down's syndrome: cost effectiveness analysis of computer simulation","volume":"338","author":"Gekas","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ejhg.2010.138","article-title":"Rapid testing versus karyotyping in Down's syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalities","volume":"19","author":"Gekas","year":"2011","journal-title":"European Journal of Human Genetics"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajog.2010.09.017","article-title":"Cost-effectiveness and accuracy of prenatal Down syndrome screening strategies: should the combined test continue to be widely used?","volume":"204","author":"Gekas","year":"2011","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/pd.1607","article-title":"Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities?","volume":"27","author":"Gerovassili","year":"2007","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1097-0223(199802)18:2<123::AID-PD221>3.0.CO;2-6","article-title":"Is maternal serum triple screening a better predictor of Down syndrome in female than in male fetuses?","volume":"18","author":"Ghidini","year":"1998","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/pd.2592","article-title":"The effect of fetal gender in predicting Down syndrome using long bone ultrasonographic measurements","volume":"30","author":"Goetzinger","year":"2010","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/096914139500200407","article-title":"Screening for Down's syndrome: the first two years experience in Bristol","volume":"2","author":"Goldie","year":"1995","journal-title":"Journal of Medical Screening"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1590\/S0100-72032008000100002","article-title":"[Predictive value for fetal outcome of Doppler velocimetry of the ductus venosus between the 11th and the 14th gestation week]. [Portuguese]","volume":"30","author":"Gollo","year":"2008","journal-title":"Revista Brasileira de Ginecologia e Obstetricia"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.7863\/jum.2004.23.12.1619","article-title":"Phenotypic characteristics of absent and hypoplastic nasal bones in fetuses with down syndrome: Description by 3-dimensional ultrasonography and clinical significance","volume":"23","author":"Gon\u00e7alves","year":"2004","journal-title":"Journal of Ultrasound in Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/pd.1970140509","article-title":"Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme","volume":"14","author":"Goodburn","year":"1994","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0247|cit247","first-page":"990","article-title":"[FISH technique in aneuplodies prenatal diagnosis]. [Romanian]","volume":"111","author":"Gorduza","year":"2007","journal-title":"Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/uog.7538","article-title":"Mitral valve-tricuspid valve distance as a sonographic marker of trisomy 21","volume":"35","author":"Grace","year":"2010","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0249|cit249","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/ajmg.a.33370","article-title":"Chromosome abnormalities investigated by non-invasive prenatal testing account for approximately 50% of fetal unbalances associated with relevant clinical phenotypes","volume":"Part A. 152A","author":"Grati","year":"2010","journal-title":"American Journal of Medical Genetics"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.7863\/jum.2009.28.10.1325","article-title":"Reevaluating humeral length for the detection of fetal trisomy 21","volume":"28","author":"Gray","year":"2009","journal-title":"Journal of Ultrasound in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0251|cit251","first-page":"262","article-title":"[Birth defects in the Czech Republic--the prenatal diagnostic]. [Czech]","volume":"72","author":"Gregor","year":"2007","journal-title":"Ceska Gynekologie"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0252|cit252","first-page":"44","article-title":"[Prenatal diagnostics of chromosomal aberrations Czech Republic: 1994-2007]. [Czech]","volume":"74","author":"Gregor","year":"2009","journal-title":"Ceska Gynekologie"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0253|cit253","first-page":"S27","article-title":"[Prenatal genetic screening: biochemical markers of the first and second quarter]. [Spanish]","volume":"77","author":"Grether Gonz\u00e1lez","year":"2009","journal-title":"Ginecologia y Obstetricia de Mexico"},{"issue":"1-2","key":"10.1002\/14651858.CD011975-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-3782(01)00251-1","article-title":"Maternal serum urea resistant alkaline phosphatase in Down syndrome pregnancy","volume":"67","author":"Grozdea","year":"2002","journal-title":"Early Human Development"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1373\/clinchem.2010.146472","article-title":"Simultaneous detection of trisomies 13, 18, and 21 with multiplex ligation-dependent probe amplification-based real-time PCR","volume":"56","author":"Guo","year":"2010","journal-title":"Clinical Chemistry"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejogrb.2003.12.014","article-title":"Screening for trisomy 21 in Flanders: a 10 years review of 40.490 pregnancies screened by maternal serum","volume":"115","author":"Gyselaers","year":"2004","journal-title":"European Journal of Obstetrics, Gynecology, & Reproductive Biology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000080578","article-title":"Single-step maternal serum screening for trisomy 21 in the era of combined or integrated screening","volume":"58","author":"Gyselaers","year":"2004","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0258|cit258","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1258\/096914106776179755","article-title":"Nuchal translucency thickness measurements for fetal aneuploidy screening: Log NT-MoM or Delta-NT, performer-specific medians and ultrasound training","volume":"13","author":"Gyselaers","year":"2006","journal-title":"Journal of Medical Screening"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/uog.2780","article-title":"Sequential triage in the first trimester may enhance advanced ultrasound scanning in population screening for trisomy 21","volume":"27","author":"Gyselaers","year":"2006","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/pd.1970151208","article-title":"Repeat maternal serum testing for Down's syndrome screening using multiple markers with special reference to free alpha and free \u00df-hCG","volume":"15","author":"Hackshaw","year":"1995","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0261|cit261","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1097-0223(200101)21:1<58::AID-PD964>3.0.CO;2-9","article-title":"Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markers","volume":"21","author":"Hackshaw","year":"2001","journal-title":"Prenatal Diagnosis"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0262|cit262","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJM199208273270902","article-title":"Prenatal screening for Down's syndrome with use of maternal serum markers","volume":"327","author":"Haddow","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"30","key":"10.1002\/14651858.CD011975-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1556\/oh.2007.28068","article-title":"[Rapid diagnosis of fetal chromosomal abnormalities by fluorescence in situ hybridization]. [Hungarian]","volume":"148","author":"Hadzsiev","year":"2007","journal-title":"Orvosi Hetilap"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0264|cit264","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1469-0705.1995.06050330.x","article-title":"Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency","volume":"6","author":"Hafner","year":"1995","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/(SICI)1097-0223(199809)18:9<893::AID-PD362>3.0.CO;2-E","article-title":"Comparison of urinary free \u00df (hCG) and \u00df-core (hCG) in prenatal screening for chromosomal abnormalities","volume":"18","author":"Hallahan","year":"1998","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0266|cit266","first-page":"378","article-title":"Clinical and cytogenetic findings on 31,615 mid-trimester amniocenteses","volume":"28","author":"Han","year":"2008","journal-title":"Korean Journal of Laboratory Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"231","DOI":"10.7863\/jum.2010.29.2.231","article-title":"Do race-specific definitions of short long bones improve the detection of down syndrome on second-trimester genetic sonograms?","volume":"29","author":"Harper","year":"2010","journal-title":"Journal of Ultrasound in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1258\/000456306775141876","article-title":"Second-trimester Down's syndrome serum screening: double, triple or quadruple marker testing?","volume":"43","author":"Harrison","year":"2006","journal-title":"Annals of Clinical Biochemistry"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jsgi.2006.03.001","article-title":"Nuchal translucency and first-trimester screening","volume":"13","author":"Harry","year":"2006","journal-title":"Journal of the Society for Gynecologic Investigation"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0270|cit270","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/pd.1970150104","article-title":"Maternal urinary \u00df-core fragment of hCG\/creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy","volume":"15","author":"Hayashi","year":"1995","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0271|cit271","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1471-0528.1996.tb09810.x","article-title":"Maternal urinary free \u00df-subunit of human chorionic gonadotrophin: Creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy","volume":"103","author":"Hayashi","year":"1996","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000264439","article-title":"Results and views of women in population-wide pregnancy screening for trisomy 21 in east Finland","volume":"12","author":"Heikkila","year":"1997","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/pd.1779","article-title":"Maternal serum free beta-hCG and PAPP-A in patients with habitual abortion-influence on first-trimester screening for chromosomal abnormalities","volume":"27","author":"Heinig","year":"2007","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0015-0282(16)58508-2","article-title":"Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening","volume":"66","author":"Heinonen","year":"1996","journal-title":"Fertility and Sterility"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/1097-0223(200010)20:10<781::AID-PD908>3.0.CO;2-Z","article-title":"Combined first trimester nuchal translucency and second trimester biochemical screening tests among normal pregnancies","volume":"20","author":"Herman","year":"2000","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000069377","article-title":"Correlation and overlapping between nuchal translucency and triple test among Down syndrome-affected pregnancies","volume":"18","author":"Herman","year":"2003","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0277|cit277","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/pd.1970121106","article-title":"Screening for fetal Down syndrome with maternal serum hCG and oestriol: a prospective study","volume":"12","author":"Herrou","year":"1992","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0002-9378(85)90119-X","article-title":"Maternal serum alpha-fetoprotein screening of fetal trisomies","volume":"153","author":"Hershey","year":"1985","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0279|cit279","first-page":"177","article-title":"Combining maternal age and serum alpha-fetoprotein to predict the risk of Down syndrome","volume":"68","author":"Hershey","year":"1986","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1479-828X.1993.tb02117.x","article-title":"Nuchal translucency in the first trimester","volume":"33","author":"Hewitt","year":"1993","journal-title":"Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/pd.2503","article-title":"QF-PCR as a stand-alone test for prenatal samples: the first 2 years' experience in the London region","volume":"30","author":"Hills","year":"2010","journal-title":"Prenatal Diagnosis"},{"key":"10.1002\/14651858.CD011975-BIB0282|cit282","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-1-60761-789-1_19","article-title":"FlashFISH: \"same day\" prenatal diagnosis of common chromosomal aneuploidies","volume":"659","author":"Ho","year":"2010","journal-title":"Methods in Molecular Biology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/pd.1970120312","article-title":"CA-125 as a maternal serum marker for Down's syndrome in the first and second trimesters","volume":"12","author":"Hogdall","year":"1992","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0284|cit284","first-page":"461","article-title":"Screening tests in pregnancy","volume":"23","author":"Anon","year":"2001","journal-title":"Hong Kong Practitioner"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0285|cit285","first-page":"359","article-title":"Costs and effects of prenatal screening methods for Down syndrome and neural tube defects","volume":"11","author":"Hoogendoorn","year":"2008","journal-title":"Community Genetics"},{"issue":"7235","key":"10.1002\/14651858.CD011975-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.320.7235.606","article-title":"Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans","volume":"320","author":"Howe","year":"2000","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0287|cit287","first-page":"598","article-title":"[Antenatal screening of maternal alpha-fetoprotein with dried-blood spot samples on filter paper]. [Chinese]","volume":"90","author":"Hsiao","year":"1991","journal-title":"Journal of the Formosan Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0288|cit288","first-page":"234","article-title":"Maternal urine alpha-fetoprotein concentrations between 14 and 21 weeks of gestation","volume":"22","author":"Hsieh","year":"1999","journal-title":"Changgeng Yi Xue Za Zhi"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0289|cit289","first-page":"181","article-title":"Influence of maternal age and weight on second-trimester serum alpha-fetoprotein, total and free \u00df human chorionic gonadotropin levels","volume":"20","author":"Hsu","year":"1997","journal-title":"Changgeng Yi Xue Za Zhi"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0290|cit290","first-page":"277","article-title":"Midtrimester maternal serum free \u00df-human chorionic gonadotropin levels: normal reference values for Taiwanese women","volume":"21","author":"Hsu","year":"1998","journal-title":"Changgeng Yi Xue Za Zhi"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0291|cit291","first-page":"11","article-title":"Urine free \u00df-human chorionic gonadotropin levels between 14 and 21 weeks of gestation in Taiwanese pregnancies","volume":"22","author":"Hsu","year":"1999","journal-title":"Changgeng Yi Xue Za Zhi"},{"issue":"35","key":"10.1002\/14651858.CD011975-BIB0292|cit292","first-page":"2476","article-title":"[Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province]. [Chinese]","volume":"87","author":"Hu","year":"2007","journal-title":"Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal]"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0293|cit293","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/pd.537","article-title":"Maternal serum marker medians in Aboriginal Canadian women","volume":"23","author":"Huang","year":"2003","journal-title":"Prenatal Diagnosis"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0294|cit294","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/pd.1867","article-title":"Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies","volume":"27","author":"Huang","year":"2007","journal-title":"Prenatal Diagnosis"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/pd.1866","article-title":"Racial differences in first trimester nuchal translucency","volume":"27","author":"Huang","year":"2007","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0296|cit296","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/uog.1720","article-title":"Doppler assessment of cardiac function at 11-14 weeks' gestation in fetuses with normal and increased nuchal translucency","volume":"24","author":"Huggon","year":"2004","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0297|cit297","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/humrep\/deg153","article-title":"Maternal serum hCG and alpha-fetoprotein levels in pregnancies conceived after IVF or ICSI with fresh and frozen-thawed embryos","volume":"18","author":"Hui","year":"2003","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0298|cit298","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/uog.1846","article-title":"Nuchal translucency in pregnancies conceived after assisted reproduction technology","volume":"25","author":"Hui","year":"2005","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0299|cit299","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ehbc.2004.02.021","article-title":"Combined serum and nuchal translucency screening in the first trimester achieves 85% to 90% detection rate for Down and Edward syndromes","volume":"8","author":"Hult\u00e9n","year":"2004","journal-title":"Evidence-Based Healthcare"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0300|cit300","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0301-5629(03)01048-2","article-title":"Nuchal translucence incorporated into a one-stage multifactorial screening model for Down syndrome prediction at second-trimester pregnancy","volume":"29","author":"Hung","year":"2003","journal-title":"Ultrasound in Medicine & Biology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0301|cit301","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1447-0756.2008.00747.x","article-title":"Fetal nasal bone length and Down syndrome during the second trimester in a Chinese population","volume":"34","author":"Hung","year":"2008","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0302|cit302","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/pd.1970131004","article-title":"Serum PAPP-A measurements in first-trimester screening for Down syndrome","volume":"13","author":"Hurley","year":"1993","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0303|cit303","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/pd.994","article-title":"Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus","volume":"24","author":"Huttly","year":"2004","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0304|cit304","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1515\/JPM.2004.137","article-title":"Evaluation of second trimester maternal serum screening for Down's Syndrome using the Spiegelhalter-Knill-Jones (S-KJ) approach","volume":"32","author":"Hwa","year":"2004","journal-title":"Journal of Perinatal Medicine"},{"issue":"Suppl","key":"10.1002\/14651858.CD011975-BIB0305|cit305","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0378-3782(96)01818-X","article-title":"Urinary analysis for Down's syndrome: Is the measurement of urinary \u00df-core the future of biochemical screening for Down's syndrome","volume":"47","author":"Iles","year":"1996","journal-title":"Early Human Development"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/01443619409027596","article-title":"Second trimester maternal serum placental alkaline phosphatase concentrations in Down's syndrome","volume":"14","author":"Ind","year":"1994","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0307|cit307","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.gyobfe.2010.10.008","article-title":"[Combined screening for Down syndrome in Marseille multidisciplinary prenatal centers]. [French]","volume":"38","author":"Ivorra-Deleuze","year":"2010","journal-title":"Gynecologie, Obstetrique & Fertilite"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0308|cit308","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1600-0412.2011.01156.x","article-title":"Implications of a first trimester Down syndrome screening program on timing of malformation detection","volume":"90","author":"Jakobsen","year":"2011","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0309|cit309","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/14722240500190673","article-title":"Fetal nasal bone: review of first trimester findings","volume":"5","author":"Jean-Pierre","year":"2005","journal-title":"Ultrasound Review of Obstetrics and Gynecology"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0310|cit310","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pd.1970110706","article-title":"First-trimester maternal serum alpha-fetoprotein and chorionic gonadotropin in aneuploid pregnancies","volume":"11","author":"Johnson","year":"1991","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0311|cit311","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0002-9378(12)90906-0","article-title":"First-trimester simple hygroma: cause and outcome","volume":"168","author":"Johnson","year":"1993","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0312|cit312","first-page":"501","article-title":"MULTISCAN--a Scandinavian multicenter second trimester obstetric ultrasound and serum screening study","volume":"78","author":"Jorgensen","year":"1999","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0313|cit313","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1093\/humrep\/dem154","article-title":"Elevated levels of total (maternal and fetal) beta-globin DNA in maternal blood from first trimester pregnancies with trisomy 21","volume":"22","author":"Jorgez","year":"2007","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0314|cit314","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1034\/j.1600-0412.1998.770504.x","article-title":"Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination","volume":"77","author":"Josefsson","year":"1998","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0315|cit315","first-page":"257","article-title":"First-trimester Down's syndrome screening by fetal nuchal translucency measurement in Taiwan","volume":"100","author":"Jou","year":"2001","journal-title":"Journal of the Formosan Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0316|cit316","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/pd.1641","article-title":"Ultrasonographic measurement of fetal nasal bone length in the second trimester in Korean population","volume":"27","author":"Jung","year":"2007","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0317|cit317","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.AOG.0000191301.63871.c6","article-title":"Relation between increased fetal nuchal translucency thickness and chromosomal defects.[see comment]","volume":"107","author":"Kagan","year":"2006","journal-title":"Obstetrics and Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0318|cit318","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/pd.1793","article-title":"Dose dependency between cigarette consumption and reduced maternal serum PAPP-A levels at 11-13+6 weeks of gestation","volume":"27","author":"Kagan","year":"2007","journal-title":"Prenatal Diagnosis"},{"issue":"13","key":"10.1002\/14651858.CD011975-BIB0319|cit319","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/pd.2149","article-title":"Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation","volume":"28","author":"Kagan","year":"2008","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0320|cit320","first-page":"93","article-title":"Humerus length measurement in Down syndrome screening","volume":"34","author":"Kalelioglu","year":"2007","journal-title":"Clinical and Experimental Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0321|cit321","first-page":"181","article-title":"Study of the efficiency of screening for trisomy 21 based on maternal serum levels of AFP and hCG combined with maternal age","volume":"18","author":"Kautzmann","year":"1995","journal-title":"Journal of Clinical Ligand Assay"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0322|cit322","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/AOG.0b013e3181a9479e","article-title":"Triple-marker prenatal screening program for chromosomal defects","volume":"114","author":"Kazerouni","year":"2009","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0323|cit323","first-page":"274","article-title":"Maternal serum screening for neural tube defects and Down syndrome","volume":"5","author":"Keith","year":"1992","journal-title":"Clinical Laboratory Science"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0324|cit324","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000078499","article-title":"Nasal bone measurement during the 1st trimester: is it useful?","volume":"58","author":"Kelekci","year":"2004","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0325|cit325","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/0002-9378(95)91376-9","article-title":"Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-\u00df subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.[see comment]","volume":"173","author":"Kellner","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0326|cit326","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0002-9378(95)90007-1","article-title":"The advantages of using triple-marker screening for chromosomal abnormalities","volume":"172","author":"Kellner","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0327|cit327","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/(SICI)1097-0223(199712)17:12<1135::AID-PD217>3.0.CO;2-E","article-title":"Levels of urinary \u00df-core fragment, total oestriol, and the ratio of the two in second-trimester screening for Down syndrome","volume":"17","author":"Kellner","year":"1997","journal-title":"Prenatal Diagnosis"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0328|cit328","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/pd.2057","article-title":"Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks","volume":"28","author":"Kirkegaard","year":"2008","journal-title":"Prenatal Diagnosis"},{"issue":"14","key":"10.1002\/14651858.CD011975-BIB0329|cit329","first-page":"1152","article-title":"[Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome]. [Danish]","volume":"170","author":"Kjaergaard","year":"2008","journal-title":"Ugeskrift for Laeger"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0330|cit330","first-page":"23","article-title":"Maternal serum alpha fetoprotein screening for fetal down syndrome","volume":"13","author":"Knight","year":"1990","journal-title":"Journal of Clinical Immunoassay"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0331|cit331","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jms.8.1.2","article-title":"Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening","volume":"8","author":"Knight","year":"2001","journal-title":"Journal of Medical Screening"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0332|cit332","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/pd.1305","article-title":"Integrated serum screening for Down syndrome in primary obstetric practice","volume":"25","author":"Knight","year":"2005","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0333|cit333","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/01.gco.0000192966.29449.01","article-title":"First-trimester screening: Lessons from clinical trials and implementation","volume":"18","author":"Koos","year":"2006","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0334|cit334","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/(SICI)1097-0223(199609)16:9<797::AID-PD948>3.0.CO;2-M","article-title":"Nuchal translucency cannot be used as a screening test for chromosomal abnormalities in the first trimester of pregnancy in a routine ultrasound practice.[see comment]","volume":"16","author":"Kornman","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0335|cit335","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1097-0223(199702)17:2<135::AID-PD41>3.0.CO;2-P","article-title":"Maternal urinary \u00df-core hCG in chromosomally abnormal pregnancies in the first trimester","volume":"17","author":"Kornman","year":"1997","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0336|cit336","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1701-2163(16)35510-4","article-title":"Prenatal screening for fetal aneuploidy","volume":"29","author":"Kotaska","year":"2007","journal-title":"Journal of Obstetrics & Gynaecology Canada: JOGC"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0337|cit337","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/(SICI)1096-8628(19980113)75:2<176::AID-AJMG10>3.0.CO;2-M","article-title":"Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus","volume":"75","author":"Kramer","year":"1998","journal-title":"American Journal of Medical Genetics"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0338|cit338","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0002-9378(96)70436-2","article-title":"First-trimester Down syndrome screening: free \u00df-human chorionic gonadotropin and pregnancy-associated plasma protein A","volume":"174","author":"Krantz","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0339|cit339","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/pd.1188","article-title":"Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program","volume":"25","author":"Krantz","year":"2005","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0340|cit340","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/uog.4029","article-title":"Genetic sonography after first-trimester Down syndrome screening","volume":"29","author":"Krantz","year":"2007","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0341|cit341","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/pd.1970130306","article-title":"Racial differences in maternal serum human chorionic gonadotropin and unconjugated oestriol levels","volume":"13","author":"Kulch","year":"1993","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0342|cit342","first-page":"69","article-title":"Down syndrome screening in Singapore--the effectiveness of a second trimester serum screening policy modelled on 29,360 pregnancies in KK Women's and Children's Hospital","volume":"39","author":"Lai","year":"1998","journal-title":"Singapore Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0343|cit343","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1023\/A:1024813708875","article-title":"First-trimester screening for Down syndrome in singleton pregnancies achieved by intrauterine insemination","volume":"20","author":"Lai","year":"2003","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0344|cit344","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/pd.1480","article-title":"Maternal serum ADAM12 levels in Down and Edwards' syndrome pregnancies at 9-12 weeks' gestation","volume":"26","author":"Laigaard","year":"2006","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0345|cit345","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/pd.1540","article-title":"ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome","volume":"26","author":"Laigaard","year":"2006","journal-title":"Prenatal Diagnosis"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0346|cit346","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/(SICI)1097-0223(199712)17:12<1101::AID-PD195>3.0.CO;2-S","article-title":"Second-trimester maternal urinary gonadotrophin peptide screening for fetal Down syndrome in Asian women","volume":"17","author":"Lam","year":"1997","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0347|cit347","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/(SICI)1097-0223(199806)18:6<585::AID-PD305>3.0.CO;2-R","article-title":"Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong","volume":"18","author":"Lam","year":"1998","journal-title":"Prenatal Diagnosis"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0348|cit348","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/humrep\/14.8.2120","article-title":"Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in pregnancies conceived after intracytoplasmic sperm injection and conventional in-vitro fertilization","volume":"14","author":"Lam","year":"1999","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0349|cit349","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/(SICI)1097-0223(199905)19:5<463::AID-PD574>3.0.CO;2-Q","article-title":"Second-trimester maternal serum inhibin-A screening for fetal Down syndrome in Asian women","volume":"19","author":"Lam","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0350|cit350","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/1097-0223(200006)20:6<487::AID-PD853>3.0.CO;2-2","article-title":"Acceptability of serum screening as an alternative to cytogenetic diagnosis of down syndrome among women 35 years or older in Hong Kong","volume":"20","author":"Lam","year":"2000","journal-title":"Prenatal Diagnosis"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0351|cit351","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pd.120","article-title":"The effect of fetal gender on second-trimester maternal serum inhibin-A concentration","volume":"21","author":"Lam","year":"2001","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0352|cit352","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/096914139600300202","article-title":"Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy","volume":"3","author":"Lambert-Messerlian","year":"1996","journal-title":"Journal of Medical Screening"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0353|cit353","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1530\/eje.0.1380425","article-title":"Second trimester levels of maternal serum total activin A and placental inhibin\/activin alpha and \u00dfA subunit messenger ribonucleic acids in Down syndrome pregnancy","volume":"138","author":"Lambert-Messerlian","year":"1998","journal-title":"European Journal of Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0354|cit354","first-page":"359","article-title":"Clinical impact of systematic genetic sonogram screening in a low-risk population","volume":"52","author":"Lauria","year":"2007","journal-title":"Journal of Reproductive Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0355|cit355","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000083911","article-title":"2nd-trimester maternal serum human chorionic gonadotropin and alpha-fetoprotein levels in male and female fetuses with Down syndrome","volume":"20","author":"Lehavi","year":"2005","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0356|cit356","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000089064","article-title":"Higher median levels of free \u00df-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down's syndrome in the Chinese population","volume":"21","author":"Leung","year":"2006","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0357|cit357","first-page":"455","article-title":"Maternal serum markers and prenatal screening for Down syndrome","volume":"50","author":"Leymarie","year":"1993","journal-title":"Archives Francaises de Pediatrie"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0358|cit358","first-page":"252","article-title":"[Clinical uses of maternal serum markers in the prenatal diagnosis] [Chinese]","volume":"33","author":"Li","year":"1998","journal-title":"Chung-Hua Fu Chan Ko Tsa Chih"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0359|cit359","first-page":"631","article-title":"[Measurement of pregnancy-associated plasma protein A in maternal peripheral blood and Down syndrome] [Chinese]","volume":"34","author":"Li","year":"1999","journal-title":"Chung-Hua Fu Chan Ko Tsa Chih"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0360|cit360","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/pd.2455","article-title":"Maternal serum anti-Mullerian hormone level is not superior to chronological age in predicting Down syndrome pregnancies","volume":"30","author":"Li","year":"2010","journal-title":"Prenatal Diagnosis"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0361|cit361","first-page":"655","article-title":"[AFP, uE3, \u00df-hCG levels applied for prenatal diagnosis of Down's syndrome]. [Chinese]","volume":"32","author":"Liao","year":"1997","journal-title":"Chung-Hua Fu Chan Ko Tsa Chih"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0362|cit362","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/humrep\/16.7.1501","article-title":"First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction","volume":"16","author":"Liao","year":"2001","journal-title":"Human Reproduction"},{"issue":"13","key":"10.1002\/14651858.CD011975-BIB0363|cit363","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/pd.497","article-title":"Nuchal index: a gestational age independent ultrasound marker for the detection of Down syndrome","volume":"22","author":"Lim","year":"2002","journal-title":"Prenatal Diagnosis"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0364|cit364","first-page":"801","article-title":"Screening for maternal serum alpha-fetoprotein: what about the low side?","volume":"136","author":"Lippman","year":"1987","journal-title":"Canadian Medical Association Journal"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0365|cit365","first-page":"156","article-title":"[Screening by maternal serum markers for Down's syndrome]. [Chinese]","volume":"25","author":"Liu","year":"2003","journal-title":"Chung-Kuo i Hsueh Ko Hsueh Yuan Hsueh Pao Acta Academiae Medicinae Sinicae"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0366|cit366","first-page":"532","article-title":"[Analysis of Down syndrome screening by maternal serum detection in mid-pregnancy]. [Chinese]","volume":"30","author":"Liu","year":"2010","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0367|cit367","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3109\/14767050903370327","article-title":"A new policy for prenatal screening and diagnosis of Down syndrome for pregnant women with advanced maternal age in a public hospital","volume":"23","author":"Lo","year":"2010","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0368|cit368","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ajmg.1320310128","article-title":"California's experience with low MS-AFP results","volume":"31","author":"Lustig","year":"1988","journal-title":"American Journal of Medical Genetics"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0369|cit369","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000165116","article-title":"Comparison of the new PRC software with the established algorithm of the FMF UK for the detection of trisomy 21 and 18\/13","volume":"24","author":"Luthgens","year":"2008","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0370|cit370","first-page":"63","article-title":"Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.[see comment]","volume":"77","author":"MacDonald","year":"1991","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0371|cit371","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/pd.1970140311","article-title":"Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A, markers for fetal Down syndrome at 8-14 weeks","volume":"14","author":"Macintosh","year":"1994","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0372|cit372","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/(SICI)1097-0223(199705)17:5<401::AID-PD40>3.0.CO;2-M","article-title":"Urinary \u00df-core hCG: Screening for aneuploidies in early pregnancy (11-14 weeks' gestation)","volume":"17","author":"Macintosh","year":"1997","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0373|cit373","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/pd.2502","article-title":"Second and first trimester estimation of risk for Down syndrome: implementation and performance in the SAFER study","volume":"30","author":"MacRae","year":"2010","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0374|cit374","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0002-9378(90)90700-H","article-title":"Maternal serum Down syndrome screening: free \u00df-protein is a more effective marker than human chorionic gonadotropin.[see comment]","volume":"163","author":"Macri","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0375|cit375","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/pd.1970140204","article-title":"Maternal serum free \u00df hCG screening: results of studies including 480 cases of Down syndrome.[see comment]","volume":"14","author":"Macri","year":"1994","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0376|cit376","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/000456329202900319","article-title":"Early detection of Down's syndrome using free \u00df human choriogonadotropin","volume":"19","author":"Spencer","year":"1992","journal-title":"Annals of Clinical Biochemistry"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0377|cit377","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0002-9378(96)70429-5","article-title":"Prenatal maternal dried blood screening with alpha-fetoprotein and free \u00df-human chorionic gonadotropin for open neural tube defect and Down syndrome","volume":"174","author":"Macri","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0378|cit378","first-page":"117","article-title":"Ultrasound clinics. Fetal nuchal fold translucency screening","volume":"43","author":"Malone","year":"1998","journal-title":"Contemporary OB\/GYN"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0379|cit379","first-page":"1066","article-title":"First-trimester sonographic screening for Down syndrome","volume":"102","author":"Malone","year":"2003","journal-title":"Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0380|cit380","first-page":"851","article-title":"[Noninvasive prenatal test in the first trimester of pregnancy (NT and estimation of beta-hCG and PAPP-A) in the diagnosis of fetal abnormalities in Polish population--comparison of the biochemistry own normal ranges and literature reported data]. [Polish]","volume":"80","author":"Mandryka-Stankewycz","year":"2009","journal-title":"Ginekologia Polska"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0381|cit381","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000053941","article-title":"Pregnancy outcome and prognosis in fetuses with increased first-trimester nuchal translucency","volume":"16","author":"Mangione","year":"2001","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0382|cit382","first-page":"3","article-title":"[Ultrasound screening for chromosomal anomalies by assessment of the fetal nasal bone during 11-14 weeks of gestation--a pilot study]. [Bulgarian]","volume":"47","author":"Markov","year":"2008","journal-title":"Akusherstvo i Ginekologiia"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0383|cit383","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/humrep\/16.4.691","article-title":"Comparison of triple serum screening and pregnancy outcome in oocyte donation versus IVF pregnancies","volume":"16","author":"Maymon","year":"2001","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0384|cit384","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pd.61","article-title":"Does a 'notched' nuchal translucency indicate Down syndrome fetuses or other adverse pregnancy outcome?","volume":"21","author":"Maymon","year":"2001","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0385|cit385","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/humrep\/17.4.1081","article-title":"Serial first- and second-trimester Down's syndrome screening tests among IVF-versus naturally-conceived singletons","volume":"17","author":"Maymon","year":"2002","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0386|cit386","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/pd.809","article-title":"Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies","volume":"24","author":"Maymon","year":"2004","journal-title":"Prenatal Diagnosis"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0387|cit387","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/pd.1256","article-title":"Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening","volume":"25","author":"Maymon","year":"2005","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0388|cit388","first-page":"70","article-title":"Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization","volume":"5","author":"McDuffie","year":"1996","journal-title":"Journal of Maternal-fetal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0389|cit389","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/clinchem\/48.4.653","article-title":"Accuracy of expected risk of Down syndrome using the second-trimester triple test","volume":"48","author":"Meier","year":"2002","journal-title":"Clinical Chemistry"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0390|cit390","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0002-9378(84)90530-1","article-title":"An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities","volume":"148","author":"Merkatz","year":"1984","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0391|cit391","first-page":"365","article-title":"The fetal nasal bone in the first trimester - Precise assessment using 3D sonography","volume":"26","author":"Merz","year":"2005","journal-title":"Ultraschall in der Medizin"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0392|cit392","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1055\/s-2008-1027958","article-title":"A new approach to calculating the risk of chromosomal abnormalities with first-trimester screening data","volume":"29","author":"Merz","year":"2008","journal-title":"Ultraschall in der Medizin"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0393|cit393","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/plac.2001.0684","article-title":"Three-dimensional ultrasound measurement of the placental volume in early pregnancy: method and correlation with biochemical placenta parameters","volume":"22","author":"Metzenbauer","year":"2001","journal-title":"Placenta"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0394|cit394","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1469-0705.2002.00655.x","article-title":"First-trimester placental volume as a marker for chromosomal anomalies: preliminary results from an unselected population","volume":"19","author":"Metzenbauer","year":"2002","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0395|cit395","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1471-0528.1999.tb08331.x","article-title":"Second trimester maternal serum \u00df human chorionic gonadotrophin and pregnancy outcome","volume":"106","author":"Mikic","year":"1999","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0396|cit396","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/pd.1970110304","article-title":"Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening","volume":"11","author":"Miller","year":"1991","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0397|cit397","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0002-9378(89)90501-2","article-title":"Predictive values relative risks and overall benefits of high and low maternal serum alpha fetoprotein screening in singleton pregnancies - new epidemiological data","volume":"161","author":"Milunsky","year":"1989","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0398|cit398","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000264310","article-title":"Maternal serum triple analyte screening and adverse pregnancy outcome","volume":"11","author":"Milunsky","year":"1996","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0399|cit399","first-page":"527","article-title":"[A study on the screening of prenatal trisomy 21 using the fucosylated alpha-fetoprotein ratio measured by a liquid-phase binding assay]. [Japanese]","volume":"77","author":"Minobe","year":"2002","journal-title":"Hokkaido Igaku Zasshi - Hokkaido Journal of Medical Science"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0400|cit400","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/pd.1930","article-title":"Effect of maternal smoking on prenatal screening for Down syndrome and trisomy 18 in the first trimester of pregnancy","volume":"28","author":"Miron","year":"2008","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0401|cit401","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1701-2163(16)34121-4","article-title":"Nuchal translucency thresholds in prenatal screening for Down syndrome and trisomy 18","volume":"31","author":"Miron","year":"2009","journal-title":"Journal of Obstetrics & Gynaecology Canada: JOGC"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0402|cit402","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/pd.2441","article-title":"Maternal plasma levels of follistatin-related gene protein in the first trimester of pregnancies with Down syndrome","volume":"30","author":"Miron","year":"2010","journal-title":"Prenatal Diagnosis"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0403|cit403","first-page":"1042","article-title":"Multicenter study for maternal serum triple markers to establish Japanese standards: Maternal serum marker study group, Japan Association of Prenatal Diagnostics","volume":"51","author":"Miyamura","year":"1999","journal-title":"Acta Obstetrica et Gynaecologica Japonica"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0404|cit404","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000020856","article-title":"Maternal serum placental growth hormone and insulinlike growth factor binding proteins 1 and 3 in pregnancies affected by fetal aneuploidy and other abnormalities: implications for prenatal diagnosis of trisomy 21","volume":"13","author":"Moghadam","year":"1998","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0405|cit405","first-page":"266","article-title":"Nuchal translucency in multiple pregnancies","volume":"41","author":"Monni","year":"2000","journal-title":"Croatian Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0406|cit406","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/14722240208500480","article-title":"New ultrasonographic markers of aneuploidies: nasal bones","volume":"2","author":"Monni","year":"2002","journal-title":"Ultrasound Review of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0407|cit407","first-page":"298","article-title":"Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome","volume":"84","author":"Mooney","year":"1994","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0408|cit408","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pd.1970","article-title":"First trimester screening for Down syndrome in rhesus negative women","volume":"28","author":"Muhcu","year":"2008","journal-title":"Prenatal Diagnosis"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0409|cit409","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/pd.1970140721","article-title":"Do racial differences exist in second-trimester maternal hCG levels? A study of 23,369 women","volume":"14","author":"Muller","year":"1994","journal-title":"Prenatal Diagnosis"},{"key":"10.1002\/14651858.CD011975-BIB0410|cit410","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0378-3782(96)01817-8","article-title":"Prenatal screening for Down syndrome: should first trimester ultrasound replace maternal serum screening?","volume":"47 Suppl","author":"Muller","year":"1996","journal-title":"Early Human Development"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0411|cit411","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/(SICI)1097-0223(199911)19:11<1086::AID-PD704>3.0.CO;2-T","article-title":"Maternal serum s100b protein is ineffective for Down syndrome screening","volume":"19","author":"Muller","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0412|cit412","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/pd.451","article-title":"Down syndrome maternal serum marker screening after 18 weeks' gestation","volume":"22","author":"Muller","year":"2002","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0413|cit413","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/pd.438","article-title":"Second trimester trisomy 21 maternal serum marker screening. Results of a countrywide study of 854,902 women","volume":"22","author":"Muller","year":"2002","journal-title":"Prenatal Diagnosis"},{"issue":"13","key":"10.1002\/14651858.CD011975-BIB0414|cit414","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/pd.756","article-title":"Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome","volume":"23","author":"Muller","year":"2003","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0415|cit415","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000063185","article-title":"Application of ductus venosus Doppler velocimetry for the detection of fetal aneuploidy in the first trimester of pregnancy","volume":"17","author":"Murta","year":"2002","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0416|cit416","first-page":"39","article-title":"Fetuses with cystic hygroma. A retrospective study","volume":"42","author":"Musone","year":"2000","journal-title":"Panminerva Medica"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0417|cit417","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/clinchem\/32.7.1412","article-title":"Alpha-fetoprotein: an enhanced-sensitivity assay for neural tube defect and Down syndrome evaluation","volume":"32","author":"Musto","year":"1986","journal-title":"Clinical Chemistry"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0418|cit418","first-page":"233","article-title":"Identification of haptoglobin alpha-2FF variants in mid-trimester maternal serum as potential markers for Down syndrome","volume":"1","author":"Myrick","year":"1990","journal-title":"Applied and Theoretical Electrophoresis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0419|cit419","first-page":"295","article-title":"Nuchal translucency as a method of first-trimester screening for aneuploidy","volume":"Suid-Afrikaanse","author":"Naidoo","year":"2008","journal-title":"South African Medical Journal"},{"issue":"211","key":"10.1002\/14651858.CD011975-BIB0420|cit420","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.53738\/REVMED.2009.5.211.1531","article-title":"[Screening for trisomy 21 in France]. [French]","volume":"5","author":"Nau","year":"2009","journal-title":"Revue Medicale Suisse"},{"issue":"190","key":"10.1002\/14651858.CD011975-BIB0421|cit421","doi-asserted-by":"crossref","first-page":"380","DOI":"10.53738\/REVMED.2009.5.190.0380","article-title":"[Trisomy 21, after a half century]. [French]","volume":"5","author":"Nau","year":"2009","journal-title":"Revue Medicale Suisse"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0422|cit422","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/(SICI)1097-0223(199612)16:12<1115::AID-PD3>3.0.CO;2-6","article-title":"Refinements in managing maternal weight adjustment for interpreting prenatal screening results","volume":"16","author":"Neveux","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0423|cit423","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1097-0223(199601)16:1<29::AID-PD801>3.0.CO;2-K","article-title":"Multiple marker screening for Down syndrome in twin pregnancies","volume":"16","author":"Neveux","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0424|cit424","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1373\/clinchem.2004.031260","article-title":"Evaluation of human chorionic gonadotropin \u00df-subunit mRNA concentrations in maternal serum in aneuploid pregnancies: a feasibility study","volume":"50","author":"Ng","year":"2004","journal-title":"Clinical Chemistry"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0425|cit425","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000263659","article-title":"Fetal nuchal oedema associated malformations and chromosomal defects","volume":"7","author":"Nicolaides","year":"1992","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0426|cit426","first-page":"145","article-title":"One-stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation","volume":"5","author":"Nicolaides","year":"2000","journal-title":"Prenatal and Neonatal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0427|cit427","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajog.2004.03.090","article-title":"Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities","volume":"191","author":"Nicolaides","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0428|cit428","first-page":"1","article-title":"[First trimester diagnosis of chromosomal defects][Polish]","volume":"76","author":"Nicolaides","year":"2005","journal-title":"Ginekologia Polska"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0429|cit429","first-page":"423","article-title":"[Sonographic features of chromosomal defects at 11(+0) to 13(+6) weeks of gestation] [Polish]","volume":"76","author":"Nicolaides","year":"2005","journal-title":"Ginekologia Polska"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0430|cit430","first-page":"593","article-title":"[Increased nuchal translucency with normal karyotype]. [Polish]","volume":"76","author":"Nicolaides","year":"2005","journal-title":"Ginekologia Polska"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0431|cit431","first-page":"179","article-title":"[Fetal nuchal translucency]. [Polish]","volume":"76","author":"Nicolaides","year":"2005","journal-title":"Ginekologia Polska"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0432|cit432","first-page":"257","article-title":"[Fetal nuchal translucency thickness and risk for chromosomal defects]. [Polish]","volume":"76","author":"Nicolaides","year":"2005","journal-title":"Ginekologia Polska"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0433|cit433","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.semperi.2005.06.001","article-title":"First-trimester screening for chromosomal abnormalities","volume":"29","author":"Nicolaides Kypros","year":"2005","journal-title":"Seminars in Perinatology (Philadelphia)"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0434|cit434","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S0015-0282(01)02871-0","article-title":"First-trimester screening for Down's syndrome in in vitro fertilization pregnancies","volume":"76","author":"Niemimaa","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0435|cit435","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/pd.286","article-title":"Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A in twin pregnancies in the first trimester","volume":"22","author":"Niemimaa","year":"2002","journal-title":"Prenatal Diagnosis"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0436|cit436","first-page":"664","article-title":"The influence of smoking on the pregnancy-associated plasma protein A, free \u00df human chorionic gonadotrophin and nuchal translucency","volume":"110","author":"Niemimaa","year":"2003","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0437|cit437","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1471-0528.1997.tb11989.x","article-title":"Maternal serum free \u00df-hCG at 10 to 14 weeks of gestation in trisomic twin pregnancies","volume":"104","author":"Noble","year":"1997","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0438|cit438","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1399-0004.1990.tb03388.x","article-title":"Maternal serum markers in screening for Down syndrome","volume":"37","author":"Norgaard Pedersen","year":"1990","journal-title":"Clinical Genetics"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0439|cit439","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/pd.1970120911","article-title":"Maternal serum CA 125 for aneuploidy detection in early pregnancy","volume":"12","author":"Norton","year":"1992","journal-title":"Prenatal Diagnosis"},{"issue":"1-2","key":"10.1002\/14651858.CD011975-BIB0440|cit440","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2298\/MPNS0702066N","article-title":"[Ultrasound screening program for chromosomal abnormalities--the first 2000 women]. [Serbian]","volume":"60","author":"Novakov-Mikic","year":"2007","journal-title":"Medicinski Pregled"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0441|cit441","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/(SICI)1096-8628(19971212)73:2<109::AID-AJMG1>3.0.CO;2-P","article-title":"Differential increases in AFP, hCG, and uE3 in twin pregnancies: Impact on attempts to quantify Down syndrome screening calculations","volume":"73","author":"O'Brien","year":"1997","journal-title":"American Journal of Medical Genetics"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0442|cit442","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0029-7844(96)00524-8","article-title":"Race-ethnicity-specific variation in multiple-marker biochemical screening: Alpha-fetoprotein, hCG, and estriol","volume":"89","author":"O'Brien","year":"1997","journal-title":"Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0443|cit443","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/01.AOG.0000148848.49752.37","article-title":"The association between fetal nasal bone hypoplasia and aneuploidy","volume":"104","author":"Odibo","year":"2004","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0444|cit444","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ajog.2007.08.031","article-title":"Defining nasal bone hypoplasia in second-trimester Down syndrome screening: does the use of multiples of the median improve screening efficacy?","volume":"197","author":"Odibo","year":"2007","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0445|cit445","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ajog.2008.06.078","article-title":"Comparison of the efficiency of second-trimester nasal bone hypoplasia and increased nuchal fold in Down syndrome screening","volume":"199","author":"Odibo","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0446|cit446","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/pd.2323","article-title":"Does the combination of fronto-maxillary facial angle and nasal bone evaluation improve the detection of Down syndrome in the second trimester?","volume":"29","author":"Odibo","year":"2009","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0447|cit447","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/uog.5373","article-title":"Prenatal detection of trisomy 21 by second-trimester ultrasound examination and maternal age in a non-selected population of 49 314 births in Norway","volume":"32","author":"Offerdal","year":"2008","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0448|cit448","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/(SICI)1097-0223(199911)19:11<1058::AID-PD685>3.0.CO;2-S","article-title":"Maternal serum superoxide dismutase (SOD): a possible marker for screening Down syndrome affected pregnancies.[see comment]","volume":"19","author":"Ognibene","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0449|cit449","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/uog.4034","article-title":"Abnormal first-trimester ductus venosus blood flow: a risk factor for adverse outcome in fetuses with normal nuchal translucency","volume":"30","author":"Oh","year":"2007","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0450|cit450","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0028-2243(89)90058-0","article-title":"Maternal serum AFP levels in the first trimester of pregnancy","volume":"30","author":"Olajide","year":"1989","journal-title":"European Journal of Obstetrics, Gynecology, & Reproductive Biology"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0451|cit451","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/(SICI)1097-0223(199608)16:8<713::AID-PD933>3.0.CO;2-X","article-title":"Triple marker screening in native Japanese women","volume":"16","author":"Onda","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0452|cit452","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/(SICI)1097-0223(199809)18:9<956::AID-PD370>3.0.CO;2-R","article-title":"Agreement between predicted risk and prevalence of Down syndrome in second-trimester triple-marker screening in Japan","volume":"18","author":"Onda","year":"1998","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0453|cit453","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1447-0756.2000.tb01355.x","article-title":"Triple marker screening for trisomy 21, trisomy 18 and open neural tube defects in singleton pregnancies of native Japanese pregnant women","volume":"26","author":"Onda","year":"2000","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0454|cit454","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/pd.390","article-title":"First trimester screening with free \u00df-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction","volume":"22","author":"Orlandi","year":"2002","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0455|cit455","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1028-4559(10)60031-9","article-title":"Abnormal ductus venosus flow and tricuspid regurgitation at 11-14 weeks' gestation have high positive predictive values for increased risk in first-trimester combined screening test: results of a pilot study","volume":"49","author":"Ozkaya","year":"2010","journal-title":"Taiwanese Journal of Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0456|cit456","first-page":"99","article-title":"Plasma protein \"A\" and chorionic gonadotropin at first trimester pregnancy","volume":"6","author":"P\u00e1ez","year":"2004","journal-title":"Informe Medico"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0457|cit457","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/uog.5129","article-title":"Fetuses with Down syndrome have an enlarged anterior fontanelle in the second trimester of pregnancy","volume":"30","author":"Paladini","year":"2007","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0458|cit458","first-page":"411","article-title":"Prenatal diagnosis using the triple test","volume":"50","author":"Palka","year":"1998","journal-title":"Minerva Ginecologica"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0459|cit459","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9378(89)80031-6","article-title":"Combining maternal serum alpha-fetoprotein measurements and age to screen for Down syndrome in pregnant women under age 35","volume":"160","author":"Palomaki","year":"1989","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0460|cit460","first-page":"675","article-title":"Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: Impact on Down syndrome screening","volume":"81","author":"Palomaki","year":"1993","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0461|cit461","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/pd.1970140112","article-title":"Human chorionic gonadotropin and unconjugated oestriol measurements in insulin-dependent diabetic pregnant women being screened for fetal Down syndrome","volume":"14","author":"Palomaki","year":"1994","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0462|cit462","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/096914139600300105","article-title":"Can reliable Down's syndrome detection rates be determined from prenatal screening intervention trials?","volume":"3","author":"Palomaki","year":"1996","journal-title":"Journal of Medical Screening"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0463|cit463","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1373\/clinchem.2005.050567","article-title":"Maternal serum invasive trophoblast antigen and first-trimester Down syndrome screening","volume":"51","author":"Palomaki","year":"2005","journal-title":"Clinical Chemistry"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0464|cit464","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0020-7292(01)00482-9","article-title":"First trimester Down Syndrome screening by nuchal translucency in a Thai population","volume":"75","author":"Panburana","year":"2001","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0465|cit465","first-page":"420","article-title":"First-trimester fetal nuchal translucency thickness and risk for trisomies","volume":"84","author":"Pandya","year":"1994","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0466|cit466","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00001703-199504000-00004","article-title":"First trimester fetal nuchal translucency","volume":"7","author":"Pandya","year":"1995","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0467|cit467","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000116743","article-title":"Human placental growth hormone is increased in maternal serum in pregnancies affected by Down syndrome","volume":"23","author":"Papadopoulou","year":"2008","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0468|cit468","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/uog.5178","article-title":"Screening for trisomy 21 during the routine second-trimester ultrasound examination in an unselected Chilean population","volume":"30","author":"Parra-Cordero","year":"2007","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"6-7","key":"10.1002\/14651858.CD011975-BIB0469|cit469","first-page":"592","article-title":"[Non invasive prenatal diagnosis of trisomy 21: dream or reality?]. [French]","volume":"23","author":"Paterlini-Brechot","year":"2007","journal-title":"Medecine Sciences : M\/S"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0470|cit470","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.0960-7692.2001.00547.x","article-title":"Measurement of fetal nuchal translucency thickness by three-dimensional ultrasound","volume":"18","author":"Paul","year":"2001","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0471|cit471","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/uog.1885","article-title":"Assessment of the gap between the fetal nasal bones at 11 to 13 + 6 weeks of gestation by three-dimensional ultrasound","volume":"25","author":"Peralta","year":"2005","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3-4","key":"10.1002\/14651858.CD011975-BIB0472|cit472","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1017\/S0001566000000179","article-title":"Analysis of triple test results in 27 cases of twin pregnancies","volume":"47","author":"Perenc","year":"1998","journal-title":"Acta Geneticae Medicae et Gemellologiae"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0473|cit473","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/humrep\/17.3.794","article-title":"Maternal serum (\u00df)-HCG and (alpha)-fetoprotein concentrations in singleton pregnancies following assisted reproduction","volume":"17","author":"Perheentupa","year":"2002","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0474|cit474","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s005990050040","article-title":"Influence of smoking habits on Down's syndrome risk evaluation at mid-trimester through biochemical screening","volume":"28","author":"Perona","year":"1998","journal-title":"International Journal of Clinical & Laboratory Research"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0475|cit475","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/uog.5404","article-title":"Prenasal thickness in trisomy-21 fetuses at 16-24 weeks of gestation","volume":"32","author":"Persico","year":"2008","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0476|cit476","first-page":"399","article-title":"[Significance of nuchal edema in fetuses of pregnant women under 35 years of age]. [Hungarian]","volume":"141","author":"Petervari","year":"2000","journal-title":"Orvosi Hetilap"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0477|cit477","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/0002-9378(89)90657-1","article-title":"Prenatal screening for Down syndrome with maternal serum human chorionic gonadotropin levels.[see comment]","volume":"161","author":"Petrocik","year":"1989","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0478|cit478","first-page":"353","article-title":"Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study","volume":"80","author":"Phillips","year":"1992","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0479|cit479","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0932-8610(12)80224-6","article-title":"Maternal serum screening for fetal Down syndrome using alpha- fetoprotein, human chorionic gonadotrophin, and unconjugated estriol in adolescents","volume":"6","author":"Phillips","year":"1993","journal-title":"Adolescent and Pediatric Gynecology"},{"issue":"35","key":"10.1002\/14651858.CD011975-BIB0480|cit480","first-page":"2691","article-title":"[Quality control of prenatal screening]. [Danish]","volume":"170","author":"Pihl","year":"2008","journal-title":"Ugeskrift for Laeger"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0481|cit481","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.7863\/jum.2003.22.11.1185","article-title":"Combined sonographic and biochemical markers for Down syndrome screening","volume":"22","author":"Pinette","year":"2003","journal-title":"Journal of Ultrasound in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0482|cit482","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/01.AOG.0000139832.79658.b9","article-title":"Sequential pathways of testing after first-trimester screening for trisomy 21","volume":"104","author":"Platt","year":"2004","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0483|cit483","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1515\/jpme.1995.23.4.283","article-title":"First trimester diagnosis of cystic hygromata using transvaginal ultrasound and cytogenetic evaluation","volume":"23","author":"Podobnik","year":"1995","journal-title":"Journal of Perinatal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0484|cit484","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ajog.2008.12.029","article-title":"Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks","volume":"200","author":"Poon","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0485|cit485","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/pd.432","article-title":"Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening","volume":"22","author":"Prefumo","year":"2002","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0486|cit486","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1471-0528.2003.00025.x-i1","article-title":"Maternal ethnic origin and fetal nasal bones at 11-14 weeks of gestation","volume":"111","author":"Prefumo","year":"2004","journal-title":"BJOG: an international journal of obstetrics and gynaecology."},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0487|cit487","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/humrep\/13.6.1706","article-title":"First trimester maternal serum concentrations of fetal antigen 2 in normal pregnancies and those affected by trisomy 21","volume":"13","author":"Price","year":"1998","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0488|cit488","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/(SICI)1097-0223(200003)20:3<221::AID-PD787>3.0.CO;2-S","article-title":"Maternal midtrimester serum AFP and free \u00df-hCG levels in in vitro fertilization twin pregnancies","volume":"20","author":"Raty","year":"2000","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0489|cit489","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/humrep\/17.2.481","article-title":"Serum free (\u00df)-HCG and alpha-fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid-trimester serum screening for Down's syndrome","volume":"17","author":"R\u00e4ty","year":"2002","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0490|cit490","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/uog.952","article-title":"Assessment of the fetal nasal bone at 11-14 weeks of gestation by three-dimensional ultrasound","volume":"23","author":"Rembouskos","year":"2004","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0491|cit491","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2007-1018865","article-title":"Human chorionic gonadotropin","volume":"10","author":"Ren","year":"1992","journal-title":"Seminars in Reproductive Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0492|cit492","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/humrep\/13.3.744","article-title":"Second trimester maternal dimeric inhibin-A in the multiple-marker screening test for Down's syndrome","volume":"13","author":"Renier","year":"1998","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0493|cit493","first-page":"104","article-title":"The role of ultrasound in screening for Down syndrome","volume":"26","author":"Resta","year":"1990","journal-title":"Birth Defects: Original Article Series"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0494|cit494","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7863\/jum.1997.16.2.101","article-title":"First trimester isolated fetal nuchal lucency: significance and outcome","volume":"16","author":"Reynders","year":"1997","journal-title":"Journal of Ultrasound in Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0495|cit495","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/000456329002700506","article-title":"The mathematical basis of multivariate risk screening: with special reference to screening for Down's syndrome associated pregnancy","volume":"27","author":"Reynolds","year":"1989","journal-title":"Annals of Clinical Biochemistry"},{"issue":"1-2","key":"10.1002\/14651858.CD011975-BIB0496|cit496","first-page":"49","article-title":"Estimation of Down's syndrome risks in the first trimester of pregnancy: Experience of testing with PAPP-A, total hCG and free \u00df- hCG levels in maternal blood samples in a German population","volume":"45","author":"Reynolds","year":"1999","journal-title":"Clinical Laboratory"},{"issue":"Pt 6","key":"10.1002\/14651858.CD011975-BIB0497|cit497","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1258\/acb.2008.008057","article-title":"Median parameters for Down's syndrome screening should be calculated using a moving time-window method","volume":"45","author":"Reynolds","year":"2008","journal-title":"Annals of Clinical Biochemistry"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0498|cit498","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/(SICI)1097-0223(199601)16:1<35::AID-PD805>3.0.CO;2-9","article-title":"Maternal serum screening for fetal Down syndrome in IVF pregnancies","volume":"16","author":"Ribbert","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0499|cit499","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/pd.1116","article-title":"Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies","volume":"25","author":"Rice","year":"2005","journal-title":"Prenatal Diagnosis"},{"issue":"2-3","key":"10.1002\/14651858.CD011975-BIB0500|cit500","first-page":"135","article-title":"Efficiency of maternal serum hCG AFP and free estriol in the identification of trisomy 21 and other complications of pregnancy","volume":"62","author":"Rich","year":"1991","journal-title":"Journal of the Alabama Academy of Science"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0501|cit501","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-0528.1995.tb11289.x","article-title":"First trimester fetal nuchal translucency: problems with screening the general population. 1","volume":"102","author":"Roberts","year":"1995","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0502|cit502","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5694\/j.1326-5377.1991.tb142124.x","article-title":"Maternal serum screening for neural tube defects and Down's syndrome.[see comment]","volume":"155","author":"Robertson","year":"1991","journal-title":"Medical Journal of Australia"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0503|cit503","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/pd.648","article-title":"Combined first- and second-trimester screening for Down syndrome: an evaluation of proMBP as a marker","volume":"23","author":"Rode","year":"2003","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0504|cit504","first-page":"332","article-title":"Combined first trimester screening for Down's syndrome is superior to quadruple test","volume":"66","author":"Ronge","year":"2006","journal-title":"Geburtshilfe und Frauenheilkunde"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0505|cit505","first-page":"55","article-title":"Multiple marker screening for women 35 and older","volume":"40","author":"Rose","year":"1995","journal-title":"Contemporary OB\/GYN"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0506|cit506","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0889-8545(05)70288-6","article-title":"Maternal serum screening for fetal genetic disorders","volume":"24","author":"Ross","year":"1997","journal-title":"Obstetrics & Gynecology Clinics of North America"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0507|cit507","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0002-9378(96)70435-0","article-title":"Nicked free \u00df-subunit of human chorionic gonadotropin: A potential new marker for Down syndrome screening","volume":"174","author":"Rotmensch","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0508|cit508","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1023\/A:1022585326896","article-title":"Midtrimester maternal serum screening after multifetal pregnancy reduction in pregnancies conceived by in vitro fertilization","volume":"16","author":"Rotmensch","year":"1999","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0509|cit509","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ajog.2006.02.046","article-title":"Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population","volume":"195","author":"Rozenberg","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0510|cit510","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/pd.440","article-title":"Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance","volume":"22","author":"Rudnicka","year":"2002","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0511|cit511","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/pd.1970120404","article-title":"Improved performance in a prenatal screening programme for Down's syndrome incorporating serum-free hCG subunit analyses","volume":"12","author":"Ryall","year":"1992","journal-title":"Prenatal Diagnosis"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0512|cit512","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/pd.108","article-title":"Karyotypes found in the population declared at increased risk of Down syndrome following maternal serum screening","volume":"21","author":"Ryall","year":"2001","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0513|cit513","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/14722240208500490","article-title":"Aneuploidy screening: ultrasound versus biochemistry","volume":"2","author":"Sabri\u00e1","year":"2002","journal-title":"Ultrasound Review of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0514|cit514","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/uog.903","article-title":"Ear length in trisomy 21 fetuses at 11-14 weeks of gestation","volume":"22","author":"Sacchini","year":"2003","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0515|cit515","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/uog.6376","article-title":"First-trimester fetal nasal bone length in an ethnic Chinese population","volume":"34","author":"Sahota","year":"2009","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0516|cit516","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/uog.7677","article-title":"Comparison of likelihood ratios of first-trimester nuchal translucency measurements: multiples of median, delta or mixture","volume":"36","author":"Sahota","year":"2010","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0517|cit517","first-page":"608","article-title":"[Specificity of biochemical markers of pregnancy second trimester]. [Spanish]","volume":"75","author":"Salazar L\u00f3pez","year":"2007","journal-title":"Ginecologia y Obstetricia de Mexico"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0518|cit518","first-page":"576","article-title":"[Evaluation of plasmatic A protein as only marker during first trimester of pregnancy]. [Spanish]","volume":"76","author":"Salazar L\u00f3pez","year":"2008","journal-title":"Ginecologia y Obstetricia de Mexico"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0519|cit519","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0002-9378(97)70287-4","article-title":"Maternal serum analyte levels in pregnancies with fetal Down syndrome resulting from translocations","volume":"177","author":"Saller","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0520|cit520","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1046\/j.0960-7692.2001.00582.x","article-title":"Relationship between nuchal translucency at 11-14 weeks and nuchal fold at 20-24 weeks of gestation","volume":"18","author":"Salomon","year":"2001","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0521|cit521","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3109\/00016349709024358","article-title":"Maternal serum screening for Down's syndrome on population basis","volume":"76","author":"Salonen","year":"1997","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0522|cit522","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/uog.1917","article-title":"Screening for Down syndrome based on maternal age or fetal nuchal translucency: a randomized controlled trial in 39,572 pregnancies","volume":"25","author":"Saltvedt","year":"2005","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0523|cit523","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1471-0528.1996.tb09630.x","article-title":"Screening for Down's syndrome: experience in an inner city health district","volume":"103","author":"Saridogan","year":"1996","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0524|cit524","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/pd.1970130613","article-title":"Ultrasound screening for chromosomal anomalies in the first trimester of pregnancy","volume":"13","author":"Savoldelli","year":"1993","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0525|cit525","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/pd.2165","article-title":"Down syndrome screening: determining the cutoff level of risk for invasive testing","volume":"29","author":"Schielen","year":"2009","journal-title":"Prenatal Diagnosis"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0526|cit526","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/pd.1487","article-title":"The \"Consecutive Combined Test\"--using double test from week 8 + 0 and nuchal translucency scan, for first trimester screening for Down syndrome","volume":"26","author":"Schiott","year":"2006","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0527|cit527","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00404-007-0324-6","article-title":"Advanced first trimester screening (AFS): an improved test strategy for the individual risk assessment of fetal aneuploidies and malformations","volume":"276","author":"Schmidt","year":"2007","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0528|cit528","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00404-006-0288-y","article-title":"Comparison of Nicolaides' risk evaluation for Down's syndrome with a novel software: an analysis of 1,463 cases","volume":"275","author":"Schmidt","year":"2007","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0529|cit529","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00404-007-0342-4","article-title":"Are nuchal translucency, pregnancy associated plasma protein-A or free-beta-human chorionic gonadotropin depending on maternal age? A multicenter study of 8,116 pregnancies","volume":"276","author":"Schmidt","year":"2007","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0530|cit530","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jcu.20509","article-title":"Improved prenatal aneuploidy screening using the novel advanced first-trimester screening algorithm: a multicenter study of 10,017 pregnancies","volume":"36","author":"Schmidt","year":"2008","journal-title":"Journal of Clinical Ultrasound"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0531|cit531","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000158520","article-title":"How imprecise may the measurement of fetal nuchal translucency be without worsening first-trimester screening?","volume":"24","author":"Schmidt","year":"2008","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0532|cit532","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2008-1004708","article-title":"[Three-dimensional scatter plot analysis to estimate the risk of foetal aneuloidy]. [German]","volume":"212","author":"Schmidt","year":"2008","journal-title":"Zeitschrift fur Geburtshilfe und Neonatologie"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0533|cit533","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00404-009-1137-6","article-title":"Analysis of the distribution shift of detected aneuploidies by age independent first trimester screening","volume":"281","author":"Schmidt","year":"2010","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0534|cit534","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/(SICI)1097-0223(199803)18:3<281::AID-PD306>3.0.CO;2-6","article-title":"The distribution of nuchal translucency at 10-13 weeks of pregnancy","volume":"18","author":"Schuchter","year":"1998","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0535|cit535","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1479-828X.1995.tb01860.x","article-title":"Maternal serum screening and routine 18-week ultrasound in the detection of all chromosomal abnormalities","volume":"35","author":"Scott","year":"1995","journal-title":"Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0536|cit536","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00013644-199000820-00003","article-title":"Ultrasound and maternal serum alpha-fetoprotein screening: a complementary relationship","volume":"8","author":"Seeds","year":"1990","journal-title":"Ultrasound Quarterly"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0537|cit537","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000292328","article-title":"Measurement of urinary free \u00df-human chorionic gonadotropin by immunoradiometric assay","volume":"40","author":"Seki","year":"1995","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0538|cit538","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/pd.564","article-title":"Midtrimester triple-test levels in women with chronic hypertension and altered renal function","volume":"23","author":"Shenhav","year":"2003","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0539|cit539","first-page":"185","article-title":"[Screening for chromosomal anomalies with maternal serum alpha-fetoprotein]. [Japanese]","volume":"41","author":"Shintaku","year":"1989","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi - Acta Obstetrica et Gynaecologica Japonica"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0540|cit540","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/pd.650","article-title":"Mid-gestation Down syndrome screening test and pregnancy outcome among unstimulated assisted-conception pregnancies","volume":"23","author":"Shulman","year":"2003","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0541|cit541","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-2007-963294","article-title":"Sonographical integrated test for detection of chromosomal aberrations","volume":"29","author":"Sieroszewski","year":"2008","journal-title":"Ultraschall in der Medizin"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0542|cit542","first-page":"289","article-title":"[Markers for trisomy 21][French]","volume":"27","author":"Simon-Bouy","year":"1999","journal-title":"Fertilite Contraception Sexualite"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0543|cit543","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0002-9378(86)90285-1","article-title":"Maternal serum alpha-fetoprotein screening: low and high values for detection of genetic abnormalities","volume":"155","author":"Simpson","year":"1986","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0544|cit544","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/875647939000600602","article-title":"Maternal serum alpha-fetoprotein screening and the role of ultrasound","volume":"6","author":"Smith","year":"1990","journal-title":"Journal of Diagnostic Medical Sonography"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0545|cit545","first-page":"176","article-title":"Does the addition of unconjugated estriol in maternal serum screening improve the detection of trisomy 21? A meta-analysis","volume":"10","author":"Smith","year":"1996","journal-title":"Clinical Laboratory Management Review"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0546|cit546","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1471-0528.1999.tb08232.x","article-title":"A six year study of the antenatal detection of fetal abnormality in six Scottish health boards","volume":"106","author":"Smith","year":"1999","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0547|cit547","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/jama.285.8.1044","article-title":"Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis.[see comment]","volume":"285","author":"Smith-Bindman","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0548|cit548","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1067\/S0002-9378(03)00721-X","article-title":"Prenatal screening for Down syndrome in England and Wales and population-based birth outcomes","volume":"187","author":"Smith-Bindman","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0549|cit549","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000264259","article-title":"Maternal age and gestational age-specific risk for chromosomal defects","volume":"10","author":"Snijders","year":"1995","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0550|cit550","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1469-0705.1999.13030167.x","article-title":"Maternal age- and gestation-specific risk for trisomy 21","volume":"13","author":"Snijders","year":"1999","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0551|cit551","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000091353","article-title":"Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany","volume":"21","author":"Soergel","year":"2006","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0552|cit552","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0002-9378(98)70199-1","article-title":"Age-specific variation in aneuploidy incidence among biochemical screening programs","volume":"179","author":"Sokol","year":"1998","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0553|cit553","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/uog.182","article-title":"Nasal bone evaluation with ultrasonography: a marker for fetal aneuploidy","volume":"22","author":"Sonek","year":"2003","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0554|cit554","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ajog.2007.03.059","article-title":"Frontomaxillary facial angles in screening for trisomy 21 at 14-23 weeks' gestation","volume":"197","author":"Sonek","year":"2007","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0555|cit555","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajog.2010.05.030","article-title":"Are second-trimester minor sonographic markers for Down syndrome useful in patients who have undergone first-trimester combined screening?","volume":"203","author":"Sood","year":"2010","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0556|cit556","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijgo.2010.06.005","article-title":"Fetal facial sonographic markers for second trimester Down syndrome screening in a Thai population","volume":"111","author":"Sooklim","year":"2010","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"6486","key":"10.1002\/14651858.CD011975-BIB0557|cit557","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1136\/bmj.290.6486.1940","article-title":"Screening for Down's syndrome using serum alpha fetoprotein: a retrospective study indicating caution","volume":"290","author":"Spencer","year":"1985","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0558|cit558","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/clinchem\/37.6.809","article-title":"Evaluation of an assay of the free \u00df-subunit of choriogonadotropin and its potential value in screening for Down's syndrome","volume":"37","author":"Spencer","year":"1991","journal-title":"Clinical Chemistry"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0559|cit559","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/000456329102800318","article-title":"Maternal serum CA125 is not a second trimester marker for Down's syndrome","volume":"28","author":"Spencer","year":"1991","journal-title":"Annals of Clinical Biochemistry"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0560|cit560","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/000456329202900504","article-title":"Free \u00df human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers.[see comment]","volume":"29","author":"Spencer","year":"1992","journal-title":"Annals of Clinical Biochemistry"},{"issue":"6907","key":"10.1002\/14651858.CD011975-BIB0561|cit561","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/bmj.307.6907.764","article-title":"Prospective study of prenatal screening for Down's syndrome with free \u00df human chorionic gonadotrophin.[see comment]","volume":"307","author":"Spencer","year":"1993","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0562|cit562","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/clinchem\/39.6.1064","article-title":"Stability of intact chorionic gonadotropin (hCG) in serum, liquid whole blood, and dried whole-blood filter-paper spots: impact on screening for Down syndrome by measurement of free \u00df-hCG subunit","volume":"39","author":"Spencer","year":"1993","journal-title":"Clinical Chemistry"},{"issue":"Pt 2","key":"10.1002\/14651858.CD011975-BIB0563|cit563","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/000456329303000226","article-title":"Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome","volume":"30","author":"Spencer","year":"1993","journal-title":"Annals of Clinical Biochemistry"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0564|cit564","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/000456329303000408","article-title":"Dual analyte immunoassay in neural tube defect and Down's syndrome screening: results of a multicentre clinical trial","volume":"30","author":"Spencer","year":"1993","journal-title":"Annals of Clinical Biochemistry"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0565|cit565","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0002-9378(12)90901-1","article-title":"Free alpha-subunit of human chorionic gonadotropin in Down syndrome","volume":"168","author":"Spencer","year":"1993","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0566|cit566","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/pd.1970150119","article-title":"The influence of gravidity on Down's syndrome screening with free \u00df hCG","volume":"15","author":"Spencer","year":"1995","journal-title":"Prenatal Diagnosis"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0567|cit567","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/(SICI)1097-0223(199612)16:12<1101::AID-PD5>3.0.CO;2-7","article-title":"Second-trimester dimeric inhibin-A in Down's syndrome screening","volume":"16","author":"Spencer","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0568|cit568","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/(SICI)1097-0223(199706)17:6<525::AID-PD105>3.0.CO;2-I","article-title":"First-trimester urine free \u00df hCG, \u00df core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free \u00df hCG","volume":"17","author":"Spencer","year":"1997","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0569|cit569","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/(SICI)1097-0223(199803)18:3<225::AID-PD239>3.0.CO;2-B","article-title":"The influence of smoking on maternal serum AFP and free \u00df hCG levels and the impact on screening for Down syndrome","volume":"18","author":"Spencer","year":"1998","journal-title":"Prenatal Diagnosis"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0570|cit570","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/clinchem\/44.11.2362","article-title":"Is prostate-specific antigen a marker for pregnancies affected by Down syndrome?","volume":"44","author":"Spencer","year":"1998","journal-title":"Clinical Chemistry"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0571|cit571","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1471-0528.1999.tb08183.x","article-title":"Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free \u00df hCG: a seven year review","volume":"106","author":"Spencer","year":"1999","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0572|cit572","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/000456329903600115","article-title":"Accuracy of Down's syndrome risks produced in a prenatal screening program","volume":"36","author":"Spencer","year":"1999","journal-title":"Annals of Clinical Biochemistry"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0573|cit573","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-0223(200004)20:4<311::AID-PD809>3.0.CO;2-P","article-title":"Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0574|cit574","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1097-0223(200002)20:2<91::AID-PD759>3.0.CO;2-X","article-title":"Screening for trisomy 21 in twin pregnancies in the first trimester using free \u00df-hCG and PAPP-A, combined with fetal nuchal translucency thickness","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenatal Diagnosis"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0575|cit575","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/(SICI)1097-0223(199911)19:11<1065::AID-PD695>3.0.CO;2-R","article-title":"The influence of smoking on maternal serum PAPP-A and free \u00df hCG levels in the first trimester of pregnancy","volume":"19","author":"Spencer","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0576|cit576","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/1097-0223(200010)20:10<792::AID-PD914>3.0.CO;2-5","article-title":"The influence of parity and gravidity on first trimester markers of chromosomal abnormality","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenatal Diagnosis"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0577|cit577","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/1097-0223(200008)20:8<648::AID-PD869>3.0.CO;2-L","article-title":"The influence of fetal sex in screening for Down syndrome in the second trimester using AFP and free \u00df-hCG","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0578|cit578","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/1097-0223(200006)20:6<491::AID-PD844>3.0.CO;2-3","article-title":"The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0579|cit579","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/(SICI)1097-0223(200005)20:5<390::AID-PD824>3.0.CO;2-B","article-title":"Maternal serum free \u00df-hCG and PAPP-A in fetal sex chromosome defects in the first trimester","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenatal Diagnosis"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0580|cit580","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/1097-0223(200008)20:8<652::AID-PD882>3.0.CO;2-6","article-title":"Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenatal Diagnosis"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0581|cit581","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/1097-0223(200008)20:8<673::AID-PD880>3.0.CO;2-5","article-title":"The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free \u00df-hCG and PAPP-A at 10-14 weeks of gestation","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0582|cit582","first-page":"1043","article-title":"Age related detection and false positive rates when screening for Down's syndrome in the first trimester using fetal nuchal translucency and maternal serum free \u00dfhCG and PAPP-A","volume":"108","author":"Spencer","year":"2001","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0583|cit583","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/pd.148","article-title":"First trimester maternal serum placenta growth factor (PIGF)concentrations in pregnancies with fetal trisomy 21 or trisomy 18","volume":"21","author":"Spencer","year":"2001","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0584|cit584","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/pd.98","article-title":"Maternal serum levels of dimeric Inhibin A in pregnancies affected by trisomy 21 in the first trimester","volume":"21","author":"Spencer","year":"2001","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0585|cit585","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/pd.53","article-title":"Maternal serum levels of total activin-A in first-trimester trisomy 21 pregnancies","volume":"21","author":"Spencer","year":"2001","journal-title":"Prenatal Diagnosis"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0586|cit586","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/pd.152","article-title":"Screening for trisomy 21 in twin pregnancies in the first trimester: does chorionicity impact on maternal serum free \u00df-hCG or PAPP-A levels?","volume":"21","author":"Spencer","year":"2001","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0587|cit587","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/pd.420","article-title":"A first trimester trisomy 13\/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free \u00df-hCG and PAPP-A","volume":"22","author":"Spencer","year":"2002","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0588|cit588","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/pd.312","article-title":"Accuracy of Down syndrome risks produced in a first-trimester screening programme incorporating fetal nuchal translucency thickness and maternal serum biochemistry","volume":"22","author":"Spencer","year":"2002","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0589|cit589","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/pd.441","article-title":"Screening for chromosomal anomalies in the first trimester: does repeat maternal serum screening improve detection rates?","volume":"22","author":"Spencer","year":"2002","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0590|cit590","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/000456320203900604","article-title":"Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy","volume":"39","author":"Spencer","year":"2002","journal-title":"Annals of Clinical Biochemistry"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0591|cit591","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1258\/000456303321610501","article-title":"The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome","volume":"40","author":"Spencer","year":"2003","journal-title":"Annals of Clinical Biochemistry"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0592|cit592","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1258\/000456303763046102","article-title":"The influence of different sample collection types on the levels of markers used for Down's syndrome screening as measured by the Kryptor Immunosassay system","volume":"40","author":"Spencer","year":"2003","journal-title":"Annals of Clinical Biochemistry"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0593|cit593","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/pd.708","article-title":"Maternal weight correction of maternal serum PAPP-A and free \u00df-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy","volume":"23","author":"Spencer","year":"2003","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0594|cit594","first-page":"279","article-title":"Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience","volume":"110","author":"Spencer","year":"2003","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0595|cit595","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/pd.819","article-title":"The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy","volume":"24","author":"Spencer","year":"2004","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0596|cit596","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/pd.1229","article-title":"The influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy","volume":"25","author":"Spencer","year":"2005","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0597|cit597","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/pd.1153","article-title":"Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations","volume":"25","author":"Spencer","year":"2005","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0598|cit598","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1258\/0004563053026880","article-title":"First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free \u00df-hCG and pregnancy-associated plasma protein-A assays.[see comment]","volume":"42","author":"Spencer","year":"2005","journal-title":"Annals of Clinical Biochemistry"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0599|cit599","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/pd.2148","article-title":"First trimester intact hCG as an early marker of trisomy 21: a promise unrecognised?","volume":"28","author":"Spencer","year":"2008","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0600|cit600","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-0223(199904)19:4<337::AID-PD553>3.0.CO;2-4","article-title":"Risk of abnormal triple screen for Down syndrome is significantly higher in women with female fetuses","volume":"19","author":"Spong","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0601|cit601","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000235880","article-title":"First-trimester uterine artery Doppler and serum pregnancy-associated plasma protein-a in preeclampsia and chromosomal defects","volume":"25","author":"Staboulidou","year":"2009","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0602|cit602","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/875647939801400603","article-title":"The use of nuchal lucency as a screening tool in first trimester sonography","volume":"14","author":"Stevens","year":"1998","journal-title":"Journal of Diagnostic Medical Sonography"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0603|cit603","first-page":"25","article-title":"A new approach of prenatal prevention of constitutional disabilities - the study of markers of maternal serum","volume":"23","author":"Stoll","year":"1992","journal-title":"Journal de Medecine de Strasbourg"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0604|cit604","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/uog.7749","article-title":"Assessment of the ductus venosus, tricuspid blood flow and the nasal bone in second-trimester screening for trisomy 21","volume":"37","author":"Stressig","year":"2011","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0605|cit605","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/pd.218","article-title":"Raised maternal serum placenta growth factor concentration during the second trimester is associated with Down syndrome","volume":"22","author":"Su","year":"2002","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0606|cit606","first-page":"344","article-title":"Ultrasonography of the fetal neck in the first and second trimesters. Part 2. Anomalies of the posterior nuchal region","volume":"46","author":"Suchet","year":"1995","journal-title":"Canadian Association of Radiologists Journal"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0607|cit607","first-page":"20","article-title":"Down syndrome screening in women under 35 with maternal serum hCG","volume":"76","author":"Suchy","year":"1990","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0608|cit608","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/096914130301000302","article-title":"Maternal serum screening in Ontario using the triple marker test","volume":"10","author":"Summers","year":"2003","journal-title":"Journal of Medical Screening"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0609|cit609","first-page":"1301","article-title":"The implications of a false positive second-trimester serum screen for Down syndrome","volume":"101","author":"Summers","year":"2003","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0610|cit610","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000087206","article-title":"Variability of nuchal translucency measurement: a multicenter study in Thailand","volume":"60","author":"Suntharasaj","year":"2005","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0611|cit611","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/GIM.0b013e3181d5d022","article-title":"Using population-based data to predict the impact of introducing noninvasive prenatal diagnosis for Down syndrome","volume":"12","author":"Susman","year":"2010","journal-title":"Genetics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0612|cit612","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/pd.836","article-title":"Sialic acid-deficient invasive trophoblast antigen (sd-ITA): a new urinary variant for gestational Down syndrome screening","volume":"24","author":"Sutton","year":"2004","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0613|cit613","first-page":"37","article-title":"Screening for trisomy 21 in the first trimester by measurement of serum PAPP-A and free \u00df-hCG","volume":"50","author":"Suzuki","year":"1998","journal-title":"Acta Obstetrica et Gynaecologica Japonica"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0614|cit614","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1471-0528.1987.tb03167.x","article-title":"Screening for Down's syndrome using an iso-risk curve based on maternal age and serum alpha-fetoprotein level","volume":"94","author":"Tabor","year":"1987","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0615|cit615","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1096-8628(19990716)85:2<123::AID-AJMG5>3.0.CO;2-M","article-title":"Predictive value of the triple screening test for the phenotype of Down syndrome","volume":"85","author":"Tanski","year":"1999","journal-title":"American Journal of Medical Genetics"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0616|cit616","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1469-0705.1998.12020112.x","article-title":"Influence of ethnic origin on nuchal translucency screening for Down's syndrome","volume":"12","author":"Thilaganathan","year":"1998","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0617|cit617","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1469-0705.1999.13040229.x","article-title":"First-trimester nuchal translucency and maternal serum biochemical screening for Down's syndrome: a happy union?","volume":"13","author":"Thilaganathan","year":"1999","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0618|cit618","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000047999","article-title":"The influence of smoking and parity on serum markers for Down's syndrome screening","volume":"17","author":"Tislaric","year":"2002","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0619|cit619","first-page":"123","article-title":"[Biochemical and ultrasonic screening of chromosomal aneuploidies in the second trimester of pregnancy]. [Hungarian]","volume":"138","author":"Torok","year":"1997","journal-title":"Orvosi Hetilap"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0620|cit620","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1373\/clinchem.2009.125922","article-title":"Performance of first-trimester screening between gestational weeks 7 and 13","volume":"55","author":"Torring","year":"2009","journal-title":"Clinical Chemistry"},{"issue":"3-4","key":"10.1002\/14651858.CD011975-BIB0621|cit621","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2298\/SARH0704153T","article-title":"[First trimester ultrasound screening of chromosomal abnormalities]. [Serbian]","volume":"135","author":"Trninic-Pjevic","year":"2007","journal-title":"Srpski Arhiv Za Celokupno Lekarstvo"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0622|cit622","first-page":"319","article-title":"Combined measurement of fetal nuchal translucency, maternal serum free \u00df-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening","volume":"100","author":"Tsai","year":"2001","journal-title":"Journal of the Formosan Medical Association"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0623|cit623","first-page":"169","article-title":"Maternal serum screening of fetal chromosomal abnormalities by AFP, UE3, hCG and free-\u00df hCG. Prospective and retrospective results","volume":"48","author":"Valerio","year":"1996","journal-title":"Minerva Ginecologica"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0624|cit624","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/pd.1970121213","article-title":"Second-trimester cancer antigen 125 and Down's syndrome.[see comment]","volume":"12","author":"Blerk","year":"1992","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0625|cit625","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/pd.1741","article-title":"The impact of maternal serum screening programs for Down syndrome in southeast Michigan, 1988-2003","volume":"27","author":"Dyke","year":"2007","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0626|cit626","first-page":"162","article-title":"Combined first trimester screening for trisomy 21: Lack of agreement between risk calculation methods","volume":"34","author":"Heesch","year":"2006","journal-title":"Journal of Perinatal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0627|cit627","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1471-0528.1991.tb10351.x","article-title":"First trimester CA 125 and Down's syndrome","volume":"98","author":"Lith","year":"1991","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0628|cit628","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/pd.1970131207","article-title":"Maternal serum CA 125 levels in pregnancies with chromosomally-normal and -abnormal fetuses. Dutch Working Party on Prenatal Diagnosis","volume":"13","author":"Lith","year":"1993","journal-title":"Prenatal Diagnosis"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD011975-BIB0629|cit629","first-page":"661","article-title":"First-trimester maternal serum immunoreactive inhibin in chromosomally normal and abnormal pregnancies. Dutch Working Party on Prenatal Diagnosis","volume":"83","author":"Lith","year":"1994","journal-title":"Obstetrics and Gynecology"},{"issue":"20","key":"10.1002\/14651858.CD011975-BIB0630|cit630","first-page":"1232","article-title":"[Low maternal serum alpha-fetoprotein concentration and Down syndrome]. [Hungarian]","volume":"127","author":"Veress","year":"1986","journal-title":"Orvosi Hetilap"},{"issue":"31","key":"10.1002\/14651858.CD011975-BIB0631|cit631","first-page":"1677","article-title":"[Prenatal screening for Down's syndrome by measuring the AFP concentration in the maternal serum]. [Hungarian]","volume":"129","author":"Veress","year":"1988","journal-title":"Orvosi Hetilap"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0632|cit632","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/pd.2138","article-title":"Risk assessment for Down syndrome with genetic sonogram in women at risk","volume":"28","author":"Vergani","year":"2008","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0633|cit633","first-page":"905","article-title":"Absent nasal bone in the prenatal detection of fetuses with trisomy 21 in a high-risk population","volume":"101","author":"Vintzileos","year":"2003","journal-title":"Obstetrics and Gynecology"},{"issue":"6653","key":"10.1002\/14651858.CD011975-BIB0634|cit634","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/bmj.297.6653.883","article-title":"Maternal serum screening for Down's syndrome in early pregnancy","volume":"297","author":"Wald","year":"1988","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0635|cit635","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1471-0528.1988.tb06602.x","article-title":"Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome","volume":"95","author":"Wald","year":"1988","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0636|cit636","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1471-0528.1991.tb13513.x","article-title":"Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome","volume":"98","author":"Wald","year":"1991","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"6850","key":"10.1002\/14651858.CD011975-BIB0637|cit637","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/bmj.305.6850.391","article-title":"Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.[see comment]","volume":"305","author":"Wald","year":"1992","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0638|cit638","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1471-0528.1992.tb14392.x","article-title":"Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome","volume":"99","author":"Wald","year":"1992","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0639|cit639","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1471-0528.1992.tb14474.x","article-title":"Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.[see comment]","volume":"99","author":"Wald","year":"1992","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0640|cit640","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1471-0528.1993.tb15307.x","article-title":"The use of free \u00df-hCG in antenatal screening for Down's syndrome.[see comment]","volume":"100","author":"Wald","year":"1993","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0641|cit641","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/pd.1970140811","article-title":"Maternal serum free alpha-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome","volume":"14","author":"Wald","year":"1994","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0642|cit642","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/096914139400100211","article-title":"Choice of serum markers in antenatal screening for Down's syndrome","volume":"1","author":"Wald","year":"1994","journal-title":"Journal of Medical Screening"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0643|cit643","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/(SICI)1097-0223(199608)16:8<699::AID-PD919>3.0.CO;2-P","article-title":"Serum markers for Down's syndrome in relation to number of previous births and maternal age","volume":"16","author":"Wald","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0644|cit644","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-0528.1996.tb09765.x","article-title":"Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.[see comment]","volume":"103","author":"Wald","year":"1996","journal-title":"British Journal of Obstetrics and Gynaecology."},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0645|cit645","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/(SICI)1097-0223(199610)16:10<923::AID-PD970>3.0.CO;2-A","article-title":"Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome","volume":"16","author":"Wald","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0646|cit646","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F","article-title":"Prenatal screening for Down's syndrome using inhibin-A as a serum marker","volume":"16","author":"Wald","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0647|cit647","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/(SICI)1097-0223(199709)17:9<821::AID-PD154>3.0.CO;2-5","article-title":"Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome.[see comment]","volume":"17","author":"Wald","year":"1997","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0648|cit648","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1097-0223(199803)18:3<291::AID-PD244>3.0.CO;2-8","article-title":"Screening for Down syndrome at 14 weeks of pregnancy","volume":"18","author":"Wald","year":"1998","journal-title":"Prenatal Diagnosis"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0649|cit649","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/(SICI)1097-0223(199907)19:7<674::AID-PD590>3.0.CO;2-M","article-title":"Maternal serum prostate-specific antigen and Down syndrome in the first and second trimesters of pregnancy","volume":"19","author":"Wald","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0650|cit650","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/(SICI)1097-0223(199906)19:6<517::AID-PD591>3.0.CO;2-2","article-title":"SP1 in pregnancies with Down syndrome in the first trimester of pregnancy","volume":"19","author":"Wald","year":"1999","journal-title":"Prenatal Diagnosis"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0651|cit651","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1471-0528.1999.tb08186.x","article-title":"Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening","volume":"106","author":"Wald","year":"1999","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0652|cit652","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM199908123410701","article-title":"Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters.[see comment]","volume":"341","author":"Wald","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0653|cit653","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/pd.627","article-title":"Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies","volume":"23","author":"Wald","year":"2003","journal-title":"Prenatal Diagnosis"},{"issue":"9360","key":"10.1002\/14651858.CD011975-BIB0654|cit654","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0140-6736(03)12680-3","article-title":"Antenatal screening for Down's syndrome with the quadruple test.[see comment]","volume":"361","author":"Wald","year":"2003","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0655|cit655","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/pd.1498","article-title":"Sequential and contingent prenatal screening for Down syndrome","volume":"26","author":"Wald","year":"2006","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0656|cit656","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2265.1994.tb02579.x","article-title":"Evaluation of maternal serum immunoreactive Inhibin Aas a first trimester marker of Down's syndrome","volume":"41","author":"Wallace","year":"1994","journal-title":"Clinical Endocrinology"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0657|cit657","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1471-0528.1997.tb14356.x","article-title":"Maternal serum inhibin-A in pregnancies complicated by insulin dependent diabetes mellitus","volume":"104","author":"Wallace","year":"1997","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0658|cit658","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3109\/14767050903287224","article-title":"The performance of second trimester long bone ratios for Down syndrome screening is influenced by gestational age","volume":"23","author":"Wang","year":"2010","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"key":"10.1002\/14651858.CD011975-BIB0659|cit659","unstructured":"Ward A Nuchal translucency measurement Synergy (http:\/\/www.highbeam.com\/doc\/1P3-866108421.html) (accessed 2007) 2005"},{"issue":"8","key":"10.1002\/14651858.CD011975-BIB0660|cit660","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/(SICI)1097-0223(199608)16:8<691::AID-PD946>3.0.CO;2-2","article-title":"Effect of allowing for ethnic group in prenatal screening for Down's syndrome","volume":"16","author":"Watt","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"10","key":"10.1002\/14651858.CD011975-BIB0661|cit661","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/(SICI)1097-0223(199610)16:10<927::AID-PD972>3.0.CO;2-0","article-title":"Maternal serum inhibin-A levels in twin pregnancies: implications for screening for Down's syndrome","volume":"16","author":"Watt","year":"1996","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0662|cit662","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jcu.20382","article-title":"Optimal crown-rump length for measuring the nuchal translucency","volume":"35","author":"Wax","year":"2007","journal-title":"Journal of Clinical Ultrasound"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0663|cit663","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/pd.130","article-title":"First-trimester maternal serum human thyroid-stimulating hormone in chromosomally normal and Down syndrome pregnancies","volume":"21","author":"Weinans","year":"2001","journal-title":"Prenatal Diagnosis"},{"issue":"5","key":"10.1002\/14651858.CD011975-BIB0664|cit664","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/pd.872","article-title":"A comparison of the impact of screen-positive results obtained from ultrasound and biochemical screening for Down syndrome in the first trimester: a pilot study","volume":"24","author":"Weinans","year":"2004","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0665|cit665","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1471-0528.2007.01238.x","article-title":"Practical issues drawn from the implementation of the integrated test for Down syndrome screening into routine clinical practice","volume":"114","author":"Weisz","year":"2007","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0666|cit666","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-2007-994526","article-title":"Trisomy 21 and cystic hygromas in early gestational age fetuses","volume":"11","author":"Welborn","year":"1994","journal-title":"American Journal of Perinatology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0667|cit667","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0002-9378(93)90007-6","article-title":"Evaluation of multiple-marker screening for Down syndrome in a statewide population","volume":"169","author":"Wenstrom","year":"1993","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0668|cit668","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0002-9378(95)91374-2","article-title":"The influence of maternal weight on human chorionic gonadotropin in the multiple-marker screening test for fetal Down syndrome","volume":"173","author":"Wenstrom","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0669|cit669","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0002-9378(95)91372-6","article-title":"Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women greater than or equal35 years old","volume":"173","author":"Wenstrom","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0670|cit670","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/pd.2650","article-title":"Use of ethnic-specific medians for Hispanic patients reduces ethnic disparities in multiple marker screening","volume":"31","author":"Wetta","year":"2011","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0671|cit671","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1469-0705.1998.12060385.x","article-title":"The significance of choroid plexus cysts, echogenic heart foci and renal pyelectasis in the first trimester","volume":"12","author":"Whitlow","year":"1998","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0672|cit672","first-page":"245","article-title":"First trimester detection of fetal abnormalities in an unselected population","volume":"10","author":"Whitlow","year":"1998","journal-title":"Contemporary Reviews in Obstetrics and Gynaecology"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0673|cit673","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1471-0528.1999.tb08432.x","article-title":"The value of sonography in early pregnancy for the detection of fetal abnormalities in an unselected population","volume":"106","author":"Whitlow","year":"1999","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0674|cit674","first-page":"397","article-title":"Expanded maternal serum alpha fetoprotein screening","volume":"84","author":"Williamson","year":"1994","journal-title":"Iowa Medicine"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0675|cit675","first-page":"591","article-title":"New first-trimester prenatal screening for down syndrome","volume":"31","author":"Wilson","year":"2000","journal-title":"Laboratory Medicine"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0676|cit676","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/pd.124","article-title":"First trimester screening for Down syndrome and assisted reproduction: no basis for concern","volume":"21","author":"Wojdemann","year":"2001","journal-title":"Prenatal Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD011975-BIB0677|cit677","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000072994","article-title":"Nasal bone hypoplasia: is it a common finding amongst chromosomally normal fetuses of southern Chinese women?","volume":"56","author":"Wong","year":"2003","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0678|cit678","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/pd.1451","article-title":"Three-stage contingent screening for Down syndrome","volume":"26","author":"Wright","year":"2006","journal-title":"Prenatal Diagnosis"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0679|cit679","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/pd.1844","article-title":"First trimester screening for Down syndrome using free beta hCG, total hCG and PAPP-A: an exploratory study","volume":"27","author":"Wright","year":"2007","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0680|cit680","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/pd.2412","article-title":"Contingent triple-screening for Down syndrome in the second trimester: a feasibility study in Mainland Chinese population","volume":"30","author":"Xie","year":"2010","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0681|cit681","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0002-9378(98)70623-4","article-title":"The role of midtrimester targeted fetal organ screening combined with the \"triple test\" and maternal age in the diagnosis of trisomy 21: a retrospective study","volume":"178","author":"Yagel","year":"1998","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0682|cit682","first-page":"1154","article-title":"Total alpha-fetoprotein and Lens culinaris agglutinin-reactive alpha-fetoprotein in fetal chromosomal abnormalities","volume":"108","author":"Yamamoto","year":"2001","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0683|cit683","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/humrep\/16.11.2438","article-title":"Lens culinaris agglutinin-reactive alpha-fetoprotein, an alternative variant to alpha-fetoprotein in prenatal screening for Down's syndrome","volume":"16","author":"Yamamoto","year":"2001","journal-title":"Human Reproduction"},{"issue":"1-2","key":"10.1002\/14651858.CD011975-BIB0684|cit684","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0009-8981(00)00381-8","article-title":"Alpha-fetoprotein microheterogeneity: a potential biochemical marker for Down's syndrome","volume":"304","author":"Yamamoto","year":"2001","journal-title":"Clinica Chimica Acta"},{"issue":"12","key":"10.1002\/14651858.CD011975-BIB0685|cit685","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/pd.178","article-title":"Effect of fetal gender on first trimester markers and on Down syndrome screening","volume":"21","author":"Yaron","year":"2001","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0686|cit686","first-page":"408","article-title":"The possibility of prenatal screening for fetal abnormalities in second-trimester pregnancies by measuring AFP, \u00df-HCG and uE-3 levels","volume":"16","author":"Ye","year":"1995","journal-title":"Xi'an Yike Daxue Xuebao"},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0687|cit687","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1447-0756.2000.tb01306.x","article-title":"Dimeric Inhibin A as a fourth marker for Down's syndrome maternal serum screening in native Japanese women","volume":"26","author":"Yoshida","year":"2000","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0688|cit688","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/uog.5230","article-title":"Fetal aberrant right subclavian artery in normal and Down syndrome fetuses","volume":"31","author":"Zalel","year":"2008","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0689|cit689","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/pd.1970111106","article-title":"Estimating the risk of a fetal autosomal trisomy at mid-trimester using maternal serum alpha-fetoprotein and age: A retrospective study of 142 pregnancies","volume":"11","author":"Zeitune","year":"1991","journal-title":"Prenatal Diagnosis"},{"issue":"11","key":"10.1002\/14651858.CD011975-BIB0690|cit690","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.7863\/jum.2005.24.11.1487","article-title":"Variation of fetal nasal bone length in second-trimester fetuses according to race and ethnicity","volume":"24","author":"Zelop","year":"2005","journal-title":"Journal of Ultrasound in Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0691|cit691","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/pd.2755","article-title":"Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters","volume":"31","author":"Zhang","year":"2011","journal-title":"Prenatal Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD011975-BIB0692|cit692","first-page":"94-6, 110","article-title":"Using maternal serum PAPP-A and other pregnancy-associated proteins in screening for fetal abnormalities","volume":"19","author":"Zhao","year":"1998","journal-title":"Xi'an Yike Daxue Xuebao"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0693|cit693","doi-asserted-by":"crossref","first-page":"463","DOI":"10.7863\/jum.2011.30.4.463","article-title":"The genetic sonogram: comparing the use of likelihood ratios versus logistic regression coefficients for Down syndrome screening","volume":"30","author":"Zhong","year":"2011","journal-title":"Journal of Ultrasound in Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0694|cit694","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1046\/j.1471-0528.2003.02180.x","article-title":"Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses","volume":"110","author":"Zoppi","year":"2003","journal-title":"BJOG: an international journal of obstetrics and gynaecology."},{"issue":"3","key":"10.1002\/14651858.CD011975-BIB0695|cit695","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003252","article-title":"Amniocentesis and chorionic villus sampling for prenatal diagnosis","author":"Alfirevic","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"329(7470)","key":"10.1002\/14651858.CD011975-BIB0696|cit696","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/bmj.329.7470.811","article-title":"Antenatal screening for Down's syndrome","volume":"9","author":"Alfirevic","year":"2004","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0697|cit697","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007384.pub2","article-title":"Antenatal screening for Down's syndrome: generic protocol","author":"Alldred","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD011975-BIB0698|cit698","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009925","article-title":"Second trimester serum tests for Down's Syndrome screening","author":"Alldred","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011975-BIB0699|cit699","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s004040050089","article-title":"A sensitive enzyme immunoassay for pregnancy-associated plasma protein A (PAPP-A): a possible first trimester method of screening for Down syndrome and other trisomies","volume":"256","author":"Bersinger","year":"1995","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"9","key":"10.1002\/14651858.CD011975-BIB0700|cit700","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/pd.1970070904","article-title":"Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities","volume":"7","author":"Bogart","year":"1987","journal-title":"Prenatal Diagnosis"},{"key":"10.1002\/14651858.CD011975-BIB0701|cit701","doi-asserted-by":"crossref","unstructured":"Cuckle HS Holding S Jones R Wallace EM Groome NP Maternal serum dimeric inhibin A in second-trimester Down's syndrome pregnancies Prenatal Diagnosis 1995 385 6","DOI":"10.1002\/pd.1970150416"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD011975-BIB0702|cit702","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0002-9378(90)90700-H","article-title":"Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin","volume":"163","author":"Macri","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"7","key":"10.1002\/14651858.CD011975-BIB0703|cit703","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/pd.1970130704","article-title":"First-trimester free beta (hCG) screening for Down syndrome","volume":"13","author":"Macri","year":"1993","journal-title":"Prenatal Diagnosis"},{"issue":"5 Pt 2","key":"10.1002\/14651858.CD011975-BIB0704|cit704","first-page":"864","article-title":"Effect of study design on the association between nuchal translucency measurement and Down syndrome","volume":"94","author":"Mol","year":"1999","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD011975-BIB0705|cit705","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02984413","article-title":"The relative effects of parental and maternal age in mongolism","volume":"27","author":"Penrose","year":"1933","journal-title":"Journal of Genetics"},{"key":"10.1002\/14651858.CD011975-BIB0706|cit706","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(66)91387-0","article-title":"Chromosome analysis of human amniotic-fluid cells\u00a0","volume":"i","author":"Steele","year":"1966","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011975-BIB0707|cit707","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(68)92656-1","article-title":"Prenatal diagnosis of Down's syndrome","volume":"ii","author":"Vaklenti","year":"1968","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011975-BIB0708|cit708","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-3-25","article-title":"The development of QUADAS:\u00a0a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews","volume":"3","author":"Whiting","year":"2003","journal-title":"BMC Medical Research Methodology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD011975\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T19:37:44Z","timestamp":1718221064000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011975"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,30]]},"references-count":708,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011975","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,30]]}}}